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PREAMBLE 
THE ORIGIN OF THE PROJECT 
Pain in the upper ann, shoulder, upper back and neck region commonly occurs in women 
who have undergone or are undergoing breast cancer therapy. The original goal of this 
project was to see if applying a therapeutic modality, such as ice, would be effective at 
controlling the post operative pain in women who had undergone a partial mastectomy 
with an axillary node dissection, as part of the breast cancer therapy. It was decided that 
several preliminary projects would have to be performed before the effectiveness of this 
therapeutic modality on shoulder pain could be properly evaluated. The preliminary 
projects included 1) Identifying an appropriate measurement tool and testing protocol to 
quantify the subjective changes in perceived pain of different individuals; 2) Identify the 
potentially problematic locations on the body where the measurement tool and testing 
protocol would be used; 3) Evaluating the testing protocol on populations that do not 
presently have any dysfunction, to understand what may be considered "normal" in the 
locations to be tested; 4) Using the testing measurement tool and testing protocol on 
patients that are going to have breast sparing surgery to note any trends that may occur; 
and 5) Finally using the measurement tool and testing protocol to collect baseline values 
on women undergoing a partial mastectomy with an axillary node dissection, having the 
women utilize ice as part of their post operative treatment plan and then retest the 
locations after a fixed period of time. 
li 
In this project only stages one (measurement tool and testing protocol), two (detennining 
the testing locations) and three (using the testing protocol on a normal population) were 
completed. The material being presented in this manuscript includes the data that was 
collected during the experimental trials of these stages. It will be speculated that the 
measuring device and the testing protocol maybe also used for various groups dealing 
with upper body dysfunction as weB as women undergoing breast cancer therapy. 
Preliminary work has begun with a local breast cancer clinic to implement projects four 
(the use of the testing protocol with breast cancer patients) and five (use the testing 
protocol to measure the effectiveness of a therapeutic intervention to reduce pain). 
lli 
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RÉSUMÉ:
 
Objectifs: le but de ce projet fut d'utiliser un algomètre manuel afin de pouvoir apprécier 
l'intensité du seuil de douleur à la pression (appelé PPT pour pain pressure threshold) sur 
huit locations cutanées différentes au niveau des membres supérieurs et du tronc chez des 
jeunes femmes en bonne santé, durant quatre jours consécutifs d'évaluation. Les 
différentes études sur ce sujet à ce jour nous permettaient de croire que les huit locations 
ne présenteraient pas de "PPT" même intensité. Le fait de noter des variations de "PPT" 
pourrait alors être une première étape dans le développement d'un protocole diagnostique 
rigoureux qui aurait un intérêt dans l'approche de différents groupes de patients 
présentant des maux et souffrances au niveau de la nuque, des épaules et des bras. 
Méthode: les mesures de l'intensité du "PPT", furent obtenues à partir de huit sites 
différents sur le bras et le tronc (coté droit seulement) de dix-neuf jeunes femmes. Tous 
les sujets testés étaient droitières, avaient des cycles menstruels réguliers et n'avaient 
présenté aucun problème musculo-squelettique relié à l'épaule au cours des six mois 
précédant la période d'évaluation. Chacune d'entre elle fut recrutée au sein de la 
population de l'Université Concordia. 
Deux thérapeutes du sport expérimentés eurent à identifier, valider et marquer les huit 
différents sites sur la peau de chaque sujet. Les deux thérapeutes du sport palpèrent 
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également les huit sites afin de détenniner la présence ou l'absence d'un nodule 
musculaire (contracture) pouvant s'associer à un point gachette " trigger point" potentiel 
à chacun des emplacements. Cette palpation fut effectuée en début et en fin de chaque 
session de tests, Au cours de quatre jours consécutifs d'évaluation, un algomètre manuel 
fut employé sur chacun des emplacements marqués afin de mesurer l'intensité du "PPT" 
sur chaque sujet. Après la collecte des mesures enregistrées par l' algomètre et 
l'évaluation palpatoire des deux thérapeutes du sport, une mesure des plis cutanés fut 
également prise pour chacune des huit sites. 
Résultats: la principale conséquence de cette recherche fut de révéler un abaissement 
significatif de l'intensité du "PPT" pour les huit emplacements lors des quatre jours 
d'évaluation. Une différence significative de l'intensité du seuil de douleur fut également 
démontrée au niveau du bras comparé aux valeurs du tronc. Les emplacements de la 
partie supérieure du bras et de la partie antérieure de l'épaule montrèrent des valeurs de 
PPT significativement plus faibles lorsque qu'ils furent comparés aux cinq autres 
emplacements du tronc et de la partie postérieure de l'épaule. 
Aucune corrélation ne fut trouvée entre l'épaisseur du pli cutané d'un emplacement et 
l'intensité du "PPT" de ce même emplacement chez les sujets testés. Les régions ayant 
une épaisseur du pli cutané plus importante n'ont pas forcément montré d'intensités de 
"PPT" plus élevées ou faibles. 
XIV 
La mesure statistique « interclass correlation scores» qui pennet d'évaluer le degré 
d'accord entre les deux thérapeutes du sport sur la présence ou l'absence d'un nodule 
musculaire associé à un point gachette fut de 0,54. Cette valeur peut être considérée 
comme basse statistiquement mais se révèle consistante et en rapport avec les autres 
valeurs du même type retrouvées dans d'autres études évaluant les habilités manuelles de 
praticiens à des fins diagnostiques. 
Cette étude peut donc fournir aux praticiens et chercheurs des indications claires à propos 
d'un protocole d'évaluation des mesures de "PPT" qui pennettrait d'obtenir des valeurs 
initiales de base au niveau des régions du bras et du tronc de jeunes femmes ne présentant 
pas de dysfonctions scapulo-humérales. Des études futures auraient donc comme intérêt 
d'utiliser ce même protocole d'évaluation chez des femmes souffrant effectivement de 
douleurs à l'épaule ou chez des femmes pouvant présenter des facteurs de risques quant 
au développement de ces mêmes douleurs lors d'interventions associées au traitement du 
cancer du sein. 
Mots-clés: PPT, cancer du sein, point gachette, douleur à la pression. 
AB8TRACT:
 
Objective: The goal of this project was to use a hand-held algometer to evaluate the 
pressure pain thresholds (PPT) of eight locations in the upper arm and torso of young 
healthy female subjects over four consecutive days of testing. Based on previous research, 
it was expected that not ail eight locations wouId have the same PPT level. Noting the 
differences in PPT levels at the eight locations would be one of the first steps in the 
development of an effective diagnostic protocol which may be used on different groups 
who are experiencing pain in the neck, shoulder and arm region. 
Methodology: PPT measures were obtained from eight different locations in the upper 
arm and torso (right side only) of 19 female subjects. Ali subjects were right hand 
dominant, had regulaI' menstrual cycles and had not experienced any musculoskeletal 
problems related to the shoulder in the 6 months prior to being tested. Ali subjects were 
recruited from the Concordia University community. 
Two experienced athletic therapists identified, agreed upon and marked the eight different 
skin surface locations on each subject. The two athletic therapists also palpated the eight 
locations to determine the presence or absence of a nodule associated with a potential 
trigger point at each of the locations. Palpation occurred at the beginning of the testing 
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session and at the end of the testing session. Over 4 consecutive days of testing, a hand­
held algometer was applied to each location to detennine the subject's pressure pain 
threshold. 
Upon completion of the algometer measurements by the data collector and the palpation 
evaluation by the two athletic therapists, skin-fold measurements were taken at each of 
the 8 locations. 
Results: The main effect of this research project showed a significant decline in the PPT 
values across all 8 locations over the 4 days of testing. A significant difference was also 
seen in the PPT values of the upper extremity compared to the PPT values of the torso. 
The locations in the upper arm and anterior shoulder were found to have significantly 
lower PPT values when compared to the other 5 locations on the torso and posterior 
shoulder. 
No correlation was found between the skin-fold thickness of a location and the PPT value 
obtained at the same location in the subjects that were tested. Regions that had higher 
levels of skin-fold thickness did not necessarily have higher or lower PPT values. 
XVil 
The interclass correlation score evaluating the agreement between the 2 athletic therapists 
on the presence or absence of a nodule associated with a trigger point was 0.54, which is 
considered low, but is consistent with scores reported in other studies evaluating 
diagnostic manual skills of clinicians. 
This project gives clear guidelines as to the testing protocol that may be used by clinicians 
and researchers on how to obtain baseline PPT measures in the upper arm and torso 
region of young women who are not experiencing any shoulder dysfunction. The next 
step in this project will be to utilize this testing protocol on women who maybe 
experiencing shoulder problems or who are at risk at developing shoulder problems such 
as women undergoing adjuvant therapy associated with breast cancer. 
Keywords: PPT, Pressure pain thresholds, Breast cancer, Trigger point 
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CHAPTERI 
INTRODUCTION -REVIEW OF THE CURRENT LITERATURE 
1.01 Breast cancer 
The advancement in diagnostic tools has led to improvements in the early detection of 
suspicious lumps in breast tissue that are associated with breast cancer (Ugnat et al., 2004). 
This has led to an increase in of the number of women being identified as being at risk for 
developing breast cancer, along with a significant decrease in morbidity in this same group 
(Jatoi and Miller, 2003, Miller et al., 2002, Ellison and Gibbons, 2004). The primary goal of 
the oncology team is to remove the cancerous tissue and preserve the patient's life, which 
certainly should be paramount (Harris et al., 1996). Unfortunately there are sorne negative 
side effects that are associated with breast cancer therapy, which include fatigue, reduction 
in the ability to complete sorne activities of daily living, swelling, edema along with the 
possibility of devèloping prolonged shoulder dysfunction (Harris et al., 1996). The 
following thesis will be focusing on the shoulder dysfunction that occurs for breast cancer 
patients and how sorne women may have certain characteristics that place them at an 
increased risk for developing pain in the upper arm, shoulder, upper back and neck region. 
2 
1.02 Adjuvant therapy 
When breast cancer is suspected, the medical team often recommends sorne form of 
adjuvant therapy. Adjuvant therapy for breast cancer typically involves four major areas 1) 
surgery 2) chemotherapy, 3) radiation therapy, and 4) hormonal therapy (Ugnat et al., 2004). 
It may be recommended to patients that at least one and sometimes ail four of the therapies 
he used to treat the breast cancer (Ugnat et al., 2004). As with many interventions, whether 
surgical or non-surgical, various adverse effects may occur (Giordani et al., 2005, Varabi, 
2003). 
When surgery takes place, an area slightly larger that the tumour itself (that includes the 
tumour) is removed from the breast region to ensure obvious cancerous tissue has been 
excised. A sampling ofaxillary Iymph nodes also takes place, to see if any migration of 
cancerous cells to other parts of the body has occurred. The sampling of lymph nodes may 
include a removal of a single lymph node or several nodes (Arnaud et al., 2004). 
Chemotherapy involves the introduction of toxic agents to the body. The cancerous cells 
that created the initial tumour in the breast of the patient are no longer recognized as being 
foreign and dangerous to the immune system of the individual. The body has begun to 
accept their presence in the body, making them a significant threat. The goal behind 
chemotherapy is to introduce toxic agents into the system and stimulate cell death, defined 
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as "apoptosis". This systemic approach kills off any cancerous cells that may have migrated 
from the original tumour location (Gajdos et al., 2002). The cell death that is initiated 
through chemotherapy not only occurs to the cancerous cells but also to the healthy cells of 
the individual. It becomes easy to see why often patients undergoing chemotherapy 
experience a significant amount of fatigue that may last weil after the chemotherapy has 
been completed. This fatigue often affects the patient's activities of daily living (Cella et al., 
2007). 
Radiotherapy or radiation therapy involves the delivery of small but concentrated amounts 
of radiation to the breast area to kill any cancerous cells that may still be in close proximity 
to the site where the tumour was removed. This local approach will cause a reddening of the 
breast area, similar to having a significant sunbum. Present day refinement of radiation 
therapy has reduced the impact on nerve endings and blood vessels in close proximity to the 
treatment area. As with chemotherapy, fatigue is a reoccurring problem for the patient (Lee 
et al., 2(07). 
One approach in honnonal therapy involves the suppression of the honnone oestrogen 
within the woman's body. Medications such as Tamoxifen try to suppress the oestrogen 
uptake by the oestrogen receptors within the breast tissue, preventing accumulation, and 
without disrupting oestrogen homeostasis elsewhere in the body (Harris et al., 1996). Drugs 
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such as Tamoxifen are also used to help maintain bone density in women, which is nonnally 
the role of oestrogen. Honnonal therapy along with chemotherapy has been shown to move 
pre-menopausal women who are undergoing treatment into menopause (Harris et al., 1996). 
Women do periodically experience hot flashes with Tamoxifen medication along with other 
side effects (Cella et al., 2007). Other problems that are associated with various fonns of 
adjuvant therapy may include cognitive symptoms, musculoskeletal pain, vasomotor 
symptoms, nausea, sexual problems, bladder problems, body image, and vaginal symptoms 
(Cella et al., 2007). 
The role of chemotherapy, radiotherapy and honnonal therapy does seem to be directly 
related to women initiating shoulder dysfunction although they do seem to aggravate any 
initial shoulder problems and cause them to last much longer than they should. It is 
important then to take a closer look at the surgical intervention. 
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1.03 Breast cancer, breast surgery and shoulder dysfunction 
During surgery for a partial mastectomy the tumour is identified as being in one of four 
quadrants of the breast, upper medial, upper lateral, lower medial and lower lateral. To 
remove the tumour an incision is typically made along the lateral border of the breast and the 
tumour is removed (Harris, 1996). 
As mentioned previously, a sampling of lymph nodes takes place to verify if any migration 
of the cancer cells to other regions of the body has occurred. Figure 1 outlines the upper 
torso and the lymphatic channels in that region; the axillary node dissection associated with 
a partial mastectomy involves the excising of tissue that will harvest lymph nodes from the 
axillary lymph node at levels 1 ( point B) and 2 (point C) and occasionally level 3 (point D). 
During the removal of the tumor, the surgeon avoids cutting into the pectoralis major 
muscle, which is in close proximity to the breast, unless it is in the area that is affected by 
the tumor. Cutting into the muscle wouId increase the risk of shoulder dysfunction for the 
patient. The surgery does require that incisions be made into the pectoral fascia, the thin 
layer of tissue which sUlTounds the chest area, since these incisions are considered less 
invasive for the patient (Harris et al., 1996). The surgeon will then try to harvest the lymph 
nodes through the same incision site where the tumour was removed. Occasionally a second 
incision will need to made, if the first incision site is far away from where the axillary lymph 
nodes may be harvested (Harris et al., 1996). 
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Figure 1: Upper torso and lymph nodes (www.breastcancer.org ) 
A Pectoraiis major muscle, B Axillary Iymph nodes: Ieveis l, 
C Axillary Iymph nodes: Ieveis II, D Axillary Iymph nodes: Ieveis III 
E Supraclavicular Iymph nodes, F InternaI mammary nodes Iymph 
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The Iymphatic system of the body is used to recover fluid in the interstitial spaces that has 
not been taken up by the ve!10us system (Guyton and Hall 2000). The harvesting of Iymph 
nodes during a partial mastectomy diminishes this uptake process, which may lead to 
pooling of the Iymph in the upper extremi ty (Taylor 2004). 
Following a partial mastectomy with an axillary Iymph node dissection, women may 
experience pain, swelling in the upper extremity, loss of shoulder mobility and a decrease in 
their ability to perfonn activities of daily living (Swenson et al., 2002). 
After having undergone surgery, it is often recornrnended that women receive additional 
therapy, which may include chemotherapy and radiotherapy. Literature reviews indicate that 
women who enter radiotherapy with shoulder dysfunction are much more likely to maintain 
these problems when re-evaluated two years post surgery. (Bendz, Fagevik and Olsen, 2002) 
A study by Maunsell, Brisson and Deschene (1993) found that 82 % of respondents reported 
at least one problem, 3 months after receiving a surgical intervention that required a partial 
mastectomy with an axillary Iymph node dissection. In this study 55 % of the women 
(n=233) reported experiencing pain in their shoulder or arm. A follow up on the women 18 
months after surgery found that 79% of the respondents (n=21O) reported having at least one 
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shoulder problem. The women reported experiencing pain, swelling or numbness in the 
shoulder and arm regions. 
It is c1ear that the need to regain shoulder mobility exists for this cohort of women, to avoid 
prolonged shoulder problems. One approach that maybe utilized to address this problem is 
to control the amount of postoperative pain the women are enduring so that they may begin 
to move their arm. 
There has been some work by different groups (Kilgour, Jones and Keyserlingk, 2007) to try 
and minimize the amount of post operative shoulder dysfunction that does take place 
through the use of a home based exercise program, but there is still much work to be done. 
Certainly having a portion of one's body removed is a very traumatic event but in 
comparison to many other types of orthopedie surgery in and around the shoulder, this 
intervention is considered minor surgery (Leidenius et aL, 2003). Oncology physicians are 
still not certain why so many women run into problems, yet many of the women who do 
undergo this regime of treatment are at risk for developing chronic arm, shoulder and neck 
problems (Leidenius et aL, 2003). 
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It is possible that women may be predisposed to developing problems in the upper body. 
Thus, it may also be important to look at other areas of daily living where women may be at 
risk for developing pain in the neck, shoulder and arm regions. These are outlined in the 
following section. 
1.04 Work-related injuries 
Women seem to be at greater risk for developing pain in the neck, shoulder and arm regions 
in comparison to men (Chesterton et al., 2003). Women often comprise a significant portion 
of different occupations (Sorock and Courtney, 1996) that are most at risk to upper body 
injuries. Men have also been shown to have repetitive injury syndrome, but not to the same 
extent as women. When evaluating the work of men and women who work on production 
lines, there is a similarity in the type of chronic injuries that occur (Westgaard and Winkel, 
1996), although women seem to be affected to a greater extent. 
In sorne instances there is a misunderstanding as to the actual demands of the tasks that are 
being petformed. Activities, specifically jobs that maybe perceived at being easy and not 
being physically demanding may in reality tum out to be quite physically demanding. A 
good example of this involved a study looking at women who worked at sewing machines 
sewing clothes. An activity that may take a short period of time to complete (on one piece of 
clothing) but because of the repetitive demands and the materials being used (such as denim 
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in jeans) it tums into a more physically challenging activity (Vezina, Tiemey and Messing, 
1992) 
Lindman et al., (1990, 1991) evaluated pain in the neck and shoulder region in women and 
noted differences in morphologieal development of the trapezius muscle between men and 
women. Lindman believes this may explain why women seem to be at greater risk for 
developing neck, shoulder and arm problems. When Lindman et al., (1990, 1991) performed 
muscle biopsies on both groups he found that women had a significantly greater proportion 
of type 1 muscle fibers when compared to men. Lindman et al., (1990, 1991) hypothesized 
that the difference in fiber composition may explain why the two genders may have ended 
up moving towards specifie type of jobs. Women who have a greater composition of type 1 
(slow twitch fatigue resistant) fibers in their trapezius muscle have a greater aerobic capacity 
and do not fatigue as quickly, as compared to type 2 fibers (Guyton and Hall, 2000; 
Lindman, Eriksson and, Thomell, 1991). Men who have a greater composition of type 2 
fibers (fast twitch non-resistant to fatigue) fibers in their trapezius muscle, are able to 
generate greater explosive contractions/force, but will fatigue faster, as compared to type 1 
fibers (Guyton and Hall, 2000; Lindman, Eriksson and, Thomell, 1991). Lindeman et al., 
(1991) also looked at the way women and men perform the same the activity, specifically 
data entry. The women involved in the study were shown to use shoulder; arm and wrist 
motions in a different manner compared to men and were expending significantly more 
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energy. The women were also often found to be much more effective at entering large 
volumes of data compared to men. Entering more data and expending more energy may also 
be two factors that have contributed to women experiencing more pain while performing this 
task in comparison to men, who used less energy as weil as entered less data. 
Work by Hooftman et al., (2004) found gender differences in relation to musculoskeletal 
pain where men were more likely to complain of pain in the low back and women were 
more likely to complain of pain in the shoulder. Hooftman et al., (2004) did not find any 
gender relationship with neck pain. 
Karlqvist, Leijon and Harenstam (2003) believe that workers that are in poor physical 
condition are at greater risk for developing pain and dysfunction in different regions of the 
body. Their work has shown that workers, both men and women, but in particular females, 
are not in good physical condition and that the jobs they perforrn on a regular basis do not 
improve their fitness level. If anything, the jobs tend to be deleterious towards the workers 
health. 
Many different occupational groups, such cashiers, dental hygienist and people who work at 
computer terminaIs have been found to have significant problems with pain in the neck, 
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shoulder and ann regions (Johansson et aL, 2003; Luime et aL, 2004). The problems 
experienced by workers have included different forms of neck and shoulder pam, 
tendonitis/tendinosis in the forearm; lateral epicondylitis (Johansson et al., 2003), and 
shoulder; supraspinatus tendonitis (Lundberg et aL, 1999), shoulder bursitis (Luime et al., 
2004), periodic numbness; thoracic outlet, brachial plexopathies (Mense and Simons, 2001), 
nerve entrapment (Pascarelli and Hsu, 2001) and carpel tunnel syndrome (Rice, Nindl and 
Pentikis, 1996). 
Workers who experience pain in the neck, upper torso and ann regions are often asked to 
perfOlm a task(s) that require a muscle or group of muscles to maintain a static position for a 
prolonged period of time (Mense and Simons, 2001). The tasks that are being performed 
often donot require a significant amount of muscular strength or force, usually having low 
biomechanical demands, but are repetitive in nature (Mense and Simons, 2001). Workers 
having pain in the neck shoulder and atm region include people who operate computers 
terminaIs, super-market cashiers (Lundberg et aL, 1999), dental personnel (Rice, Nindl and 
Pentikis, 1996; Rising et al., 2005), nursing home workers (Luime et al., 2004) and 
musicians (pascarelli and Hsu, 2001; Zaza and Farewell, 1997). A corrunon trend that is 
seen in many of these studies is the high prevalence of neck-shoulder pain in females 
(Chesterton et al., 2003). 
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There is growmg consensus that musculoskeletal disorders may be related to the 
occupational activities of the individuals (Punnett and Wegman, 2004) but it is still unclear 
how much predisposing factors play a role in a worker developing musculoskeletal 
disorders. 
As Messing et al., (2003) point out in their literature review of work demands and gender 
differences, the actual number of women who suffer injury that is associated with the tasks 
that they perfonn at their jobs may be much larger than what has been recorded to date. 
1.05 Cinderella theory 
The Cinderella syndrome theory developed by Hagg (1991) explains how repetitive 
movements may have a negative impact on the body and why women may be at greater risk 
for certain musculoskeletal disorders (Johansson et al., 2003; Ge, Madeleine and Arendt­
Nielsen, 2005). ,During active movement (whether static or dynamic) where force is 
required, motor units associated with small muscle fibers will be the first muscle fibers to be 
recruited and as the intensity of the work increases and greater force is required, motor units 
associated with larger muscle fibers will be recruited. This concept was outlined in 
Henneman's principle (Henneman, Somjen and Carpenter, 1965) concerning the order of 
recruitment of motor units. The Cinderella syndrome (Ge, Madeleine and Arendt-Nielsen, 
2005) attempts to utilize Henneman's principle (Henneman, Somjen and Carpenter, 1965) 
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of the order of muscle fiber recruitment where small muscle fibers are being asked to 
perforrn work at a low iniensity for a prolonged period of time and the larger fast twitch 
fibers being sporadically recruited. This situation may lead to excessive shearing forces at 
the level of the small slow twitch fibers and sorne forrn of dysfunction at the motor endplates 
(Mense and Simons, 2001).The shearing forces would lead to a disorganization of the actin 
and myosin cross bridges. In the story of Cinderella, Cinderella was always the first to start 
working in the moming and the last to stop working at night, similar to what maybe 
happening to the smaller fibers. One of the drawbacks with the Cinderella theory is the 
concept that during active muscle contraction the same muscle fibers (Type 1 muscle fiber 
motor units) will be continually recruited and will have limited recovery time leading to the 
same motor units of muscle fi bers being continuously contracted. We know from the 
physiology literature that during active movement, motor units of small and large muscle 
fibers will be contracted and relaxed continuously and that not ail motor units may be 
recruited at one time (Gardiner 2001). It is only through the use of electrical stimulation that 
ail motors units of small and large muscle fibers may be stimulated leading ta a muscle 
contraction (Gardiner 2001). This continuous recruitment and relaxation of the motor units 
is not really addressed in the explanation of the Cinderella theory. Nonetheless, the 
Cinderella theory is a promising theory that has led researchers to question Henneman's 
principle of recruitment especially as it pertains to repetitive work related syndromes. 
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The connection with the Cinderella hypothesis as it pertains to women is that if women 
have a greater composition of type l fibers in trapezius muscle compared to men, then it 
may explain why women appear to develop neck pain and shoulder more frequently than 
men. When perfonning a low intensity task for a long period of time, men would fatigue 
more quickly with type 2 fi bers and may be less likely to develop chronic pain in this region; 
because before the problem develops the men are more likely stop performing the required 
task. Women with a larger composition of type l fi bers in the trapezius would be able to 
perform the low intensity tasks for longer periods of time before fatigue would set in and 
might only notice the area becoming painfullong after tissue damage started to occur. 
1.06 Perception of pain 
Why women may likely experience more pain in the neck, shoulder and arm region maybe 
related to the way in which men and women process pain on a cognitive level (Nie et al., 
2005; Wahlstrom et al., 2000). A study by Sarlani et al. (2004) that evaluated gendered 
response to chronic painful stimulation found women to be less likely to habituate to the 
chronic painful stimulus in comparison to men. In the study, both groups received a 
continuous low level stimulation which was irritating but did not cause any type of tissue 
damage. Over time, men were able to adapt to the chronic painful stimulus, eventually being 
able to habituate to and! or block out the stimulus. The women in this study were less able to 
accommodate to the chronic stimulus and were less likely to develop a coping strategy 
(Sarlani et al., 2004). This lack of adaptation may also apply to the neck and shoulder 
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region, where women may have been less likely to ignore pain or develop a coping strategy 
so that they may continue to perform their job (Sarlani et al., 2004; Greenspan and McGillis, 
1994). 
A final reason why more women than men have been identified as having pain in this region 
may be related to the fact that women tend to be more verbal and forthcoming about pain 
and issues they are experiencing (Sarlani et al., 2004; Sarlani, Farooq and Greenspan, 2003; 
Sarlani and Greenspan, 2002). There is evidence that women are conscientious about taking 
care of their body and may seek out medical attention more readily than men (Sarlani et al., 
2004; Sarlani, Farooq and Greenspan, 2003; Sarlani and Greenspan, 2002). 
To summarize this section, women who work outside of the home seem to make up a 
disproportionate number of the work force that ends up coping with pain in the neck, 
shoulder and arrn. The number of women who make up this group maybe underreported. 
The risk of injury maybe related to the tasks the women perform at their jobs and there 
appears to be an underestimation of the physical demands placed on women to complete the 
different jobs. The muscle fiber composition of the trapezius muscle and possibly other 
muscles in the region may place women at greater risk for developing neck pain. Women 
may be more aware of how their body handles stress, especially when stress provokes pain, 
compared to men. 
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1.07 The role of a hand-held algometer 
One of the first challenges for this praject was to validate the efficacy of the measuring tool 
that could quantify the subjective impression of pain of an individual. Measuring devices 
such as algometers have been used to give a quantitative measure of the subjective pain 
threshold of individuals (Messing and Kilbom, 2001). The algometer has been used on 
mammals to evaluate the pressure pain threshold (PPT) of the paw, noting what pressure has 
to be applied before the mammal attempts to remove its paw fram the area (Garell, McGillis 
and Greenspan, 1996). The algometer has also been used on humans, looking at pain 
thresholds in different groups of individuals and body locations (Itoh, Okada and Kawakita, 
2004; Kosek and Ordeberg, 2000; Messing and Kilbom, 2001; Svendsen et al, 2005). 
There are at least 3 different measurements that may be derived from the algometer: 1) the 
perception of pressure when the subject first feels pressure being applied fram the 
algometer to a location on the individual; 2) Pressure pain threshold (PPT) when the 
sensation of pressure to the skin surface changes to the sensation of pain; and 3) Maximal 
pain tolerance or the maximum amount of force the individual is able to tolerate 
(Nussbaum and Downes, 1998; Persson et al., 2000; Vanderweeen et al., 1996). For this 
study, we used the PPT as a standard measure. 
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Algometers have evolved over time, moving from manual devices to electronic and 
computer assisted devices. The original algometer was a spnng loaded gauge unit that 
reguired verbal feedback from the subject as to when different thresholds have been attained. 
(Nussbaum and Downes, 1998) Electronic algometers followed, allowing subjects to depress 
hand-held switches that connect to the algometer and indicate the threshold. The electronic 
algometer also has a digital read out, which improves the testing accuracy. This change has 
lead to studies comparing the PPT val ues obtained using electronic algometers and manual 
algometers on the same locations and same subjects (Atkins et al., 1992) Electronic 
algometers have been shown to be more sensitive than manual algometers and may give a 
more accurate reflection of the subject's PPT (Atkins et al., 1992). Electronic algometers 
were also found to record lower PPT values than manual algometers. The third generation of 
algometers have computer links and are attached to support stands so that progressive loads 
maybe carefully applied and monitored (Stohler and Ashton-Miller, 2007). The electronic 
algometer was used for this study on multiple locations to be tested on each subject and in 
two different testing positions. 
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Figure: 2 Electronic algometer (hand with wristwatch) with hand-held patient switch 
(red button with subject thumb over it). 
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1.08 Factors that affect the use of the Algometer 
As researchers leamed how to use the algometer certain factors became apparent. When 
utilizing an algometer, there is a leaming curve the subject must undergo before 
understanding what sensations the data collector wants to record (Nussbaum and Downes, 
1998; Persson, Brogargh and Sjolund, 2004). The practice in sorne studies involves applying 
the algometer to the designated landmarks, discarding the first set of trials and calculating 
the mean of the subsequent tIials (Persson, Brogargh and Sjolund, 2004). For this thesis 
project, the algometer was applied to a skin surface landmark four different times. Details of 
the algometer application are presented in the methods section. 
A number of studies have looked at the reli abi lity of the algometer, between different 
evaluators. The interclass correlation of the testers has been found to be high (Nussbaum and 
Downes, 1998). This type of testing has usually occurred on the same day or days. Earlier 
studies with manual algometers used mixed groups (males and females) over consecutive 
days of testing and found little variation in PPT values or in sorne instances elevation of 
values over the testing period (Persson et al., 2000 ). 
Handedness appears to play a role in sensitivity to shoulder pain (Ozcan et al., 2004). Right 
hand dominant subjects have been shown to have a significant difference between their 
dominant and non-dominant sides in PPT scores, compared to left hand dominant subjects 
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(Ozcan et al., 2004). The non -dominant side of right handed dominant subjects was shown 
to have significantly lower pressure pain threshold values. This is in contrast to left hand 
dominant subjects who did not show as much variation in PPT scores between their 
dominant side and non-dominant sides (Ozcan et al., 2004). 
The female menstrual cycle has been recently indicated as having an impact on values 
obtained using an algometer (Bajaj et al., 2001; Sherman et al., 2005). Studies evaluating 
women's PPT values at different stages of their menstrual cycle noted variations in the 
subject's level of pain tolerance. Women showed stable palpation pain intensity ratings at 
menses, ovulatory, and midluteal phases, with increased intensity at the late luteal phase 
(Bajaj et al., 2001; Sherman et al., 2005). Many older studies have failed to include this fact 
or have not mentioned it in their methodology. It is therefore important to take into 
consideration the female subjects' menstrual cycle and standardize the starting time for aIl 
subjects, in order to collect valid data. 
To summarize this section, implementing a leaming phase for the subjects has been shown 
to be important. Mixed gender groups show different values compared to single gender 
groups, males show different values from females. Rand dominance has to be considered 
when testing ipsilateral and contralateral sides. The female menstrual cycle has only begun 
to be considered when using the algometer and may influence results. 
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1.09 Types of Pain 
For this project, we have focused on the physiological and subjective responses to pain. Pain
 
is norrnally thought of as the body's early waming system to prevent further injury to an
 
already damaged structure. A protective tissue response to stress exists in the body in
 
response to stress, strain on the tissue. Should any of the protective mechanisms that are in
 
place become over stressed or exceed the tissue's tolerance for injury, pain may result.
 
These mechanisms include level of tissue stiffness, viscoelasticity, creep of tissue,
 
uncrimping of tissue, and stress relaxation (Mcgee, Zachazewski and Quillen, 2007).
 
Crimp: under a microscope the collagen fibers have a wavy appearance in a relaxed state
 
which is known as crimp. The uncrimping of tissue occurs as the tissue is being lengthened
 
and the wavy appearance of the collagen fibers will disappear. This slack area known as
 
crimp is one of the first Iines in response to stress (Mcgee, Zachazewski and Quillen, 2007).
 
Viscoelasticity: is the primary mechanism used by tissues which include ligaments,
 
capsules and muscles to increase their length. The elasticity component enables the tissue to
 
retum to its original shape when stress has been removed (Mcgee, Zachazewski and Quillen,
 
2007).
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Creep: also considers part of viscoelasticity and is related to the continuous defOlmation of 
the tissue. The creep of the collagen fibers occurs aIl the way along the fiber. Creep allows 
for the constant lengthening of tissue in response to stress (Mcgee, Zachazewski and 
Quillen, 2007). 
Stress or force relaxation occurs when the tissue is stretched to its pathophysiological end 
of range. The tissue that has been stressed (or injured) will progressively shorten after the 
stress has been removed, with the greatest amount of stress relaxation (shortening) taking 
place between 6-8 hours after a trauma (Mcgee, Zachazewski and Quillen, 2007). 
When movements are slow and controlled (small load) or the tissue is WaIm, there is a 
plastic type of flow of the tissue where creep and stress relaxation is followed by graduaI 
tissue lengthening and eventual tissue remodeling (Mcgee, Zachazewski and Quillen, 2007). 
Tissue injury may occur with a quick movement, an uncontrolled movement, a large load 
being applied to the tissue, or nOlmalload being applied to cold tissue. When one of these 
four mechanisms occurs, there is deforrnation of the tissue and trauma, which may lead to 
injury. (Mcgee, Zachazewski and Quillen, 2007). 
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The pain that occurs with tissue injury may be classified as being transient, acute or chronic 
(Mense and Simons, 2001). 
Transient pain that lasts a few seconds to a few minutes (Mense and Simons, 2001) is an 
experience that many individuals feel on a daily basis. This is the pain associated with 
bumping into an object or an overenthusiastic handshake. This type of pain quickly 
disappears after the incident has taken place. 
Acute pain is often associated with but not exclusive to acute trauma (Mense and Simons, 
2001). Acute pain may be seen when the cell walls of tissue within the body are damaged, 
causing the release of a number of chemical agents from dopamine and norepinephrine as 
precursors, to the later release of prostagladins, which will increase nerve fiber sensitivity 
and bradykinin, which increases vascular permeability during the inflammatory response of 
the body (Guyton and Hall, 2000; Simons, 2004). This type of pain may last from 12 hours 
to 72 hours and may be perceived as intense. 
Chronic Pain may occur when the early warning system that was in place for acute pain has 
lost its function. The responses that were in place for acute pain, to prevent further damage 
and diminish symptoms, continue with chronic pain, but they do not alleviate symptoms; 
instead they continually aggravate a painful condition (Mense and Simons, 2001). Chronic 
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pain maybe associated with a specifie trauma or a systernic problem and may last a series of 
months or a whole lifetime. 
In this present thesis, we have focused on the transient pain that occurs through the use of 
the algometer being applied ta the different locations in the neck, shoulder and arrn. We 
hope ta eventually implement this testing protocol with people who are suffering with acute 
and/or chronic pain. 
1.10 Testing locations on the neck shoulder and arm region 
PPT values obtained on bony prorninences tend ta be more variable compared ta PPT values 
obtained over muscular areas (Baker, Kelly and Eston, 1997). Bony areas have been found 
ta be more sensitive and have lower PPT values compared ta muscular areas on the sarne 
individual (Baker, Kelly and Eston, 1997). Sorne studies have used bony areas (locations of 
the proximal tibia) as a benchmark to compare sensitivity at different locations. In this 
thesis, the algometer was ta be used over muscle and not bone. 
A number of different locations have been used in other research projects evaluating torso 
and upper extrernity dysfunction (Nussbaum and Downes, 1998; Persson et al., 2000; 
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Persson, Brogargh and Sjolund, 2004). In some instances, single locations have been used 
to identify PPT (Nussbaum and Downes, 1998). In other instances, researchers have tested 
multiple locations along the same muscle (Persson et al., 2000), or have done comparisons 
between muscle and bone (Baker, Kelly and Eston, 1997; Kelly and Eston, 2001; Falla and 
Farina 2005). Researchers have found that more consistent PPT values are obtained when an 
examiner has applied the algometer to a muscle. This is in comparison to applying the 
algometer to a bony location where PPT values were found to be more variable between the 
same examiner (Kosek, Ekholm and Nordemar', 1993). 
When applying the algometer ta a muscle it is important to recognize that the PPT values 
would be different if the algometer was to be applied to the mid point of the muscle 
compared to the distal or proximal ends of a muscle. In this study, the algometer was to be 
applied to the mid point of muscles for consistency. 
Sorne of the locations (trapezius, rhomboids, supraspinatus) selected for the project are 
frequently cited in other studies (Falla and Farina, 2005) and we have included other 
locations (biceps, triceps, deltoid) that are often found to be painful after a partial 
mastectomy with an axillary node dissection (McCredie et al., 2001). The clinicians who 
treat people with musculoskeletal disorders often describe a location in the middle of a 
muscle as being hypersensiti ve and thickened. This thickened structure is often thought to be 
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the cause of some of the pain and discomfort. These locations are known as trigger points 
(Davies and Davies, 2004; Mense and Simons, 2001; Takahashi et al, 2005). 
1.11 Trigger points 
A trigger point, as illustrated in Figure 3, is thought to be a hypersensitive area in a muscle 
which may cause pain (Simons, 2004). When an individual is in pain, whether acute or 
chronic pain, the person may seek advice from a doctor and treatment from a rehabilitation 
therapist. The medical professionals who evaluate patients with musculoskeletal problems 
will often try to palpate the involved area to note whether a trigger point nodule is present 
and may be a component of the patient's underlying problem (TraveJi and Simons, 1999). 
The presence of a nodule at the location of pain in muscular tissue is further confirmation of 
a potential trigger point. 
Different types of trigger points may be found by the therapist on the patient, including 
active trigger points, latent trigger points (Davies and Davies, 2004; Mense and Simons, 
2001; Travell and Siroons, 1999; Simons, 2(04), and satellite trigger points (Davies and 
Davies, 2004; Mense and Simons, 2001; Simons, 2004). An active trigger point is a location 
on the muscle that is presently causing pain which may be either local or referred (Mense 
and Simons, 2001). Referred pain is pain in a different location from where the original 
problem is located, such that pain in the trapezius may refer pain to the head region or down 
28 
the arm (Travell and Simons, 1999). The active trigger point may also restrict joint 
movement and cause the individual to seek out a remedy to reduce the pain, such as 
applying ice to the location or consulting a therapist. An active trigger point is thought to 
always provoke pain. 
A latent trigger point is only painful when pressure is applied to it, and is not considered as 
significant a problem as the active trigger point. It is common for an individual to not 
experience any pain in the area of a latent trigger point unless someone or something applies 
pressure to the area (Simons, 2004). At that point the person with the latent trigger point will 
feel pain. 
A satellite trigger point is a trigger point that will cause referred pain to multiple locations on 
the individual (Simons, 2004). When pressure is applied to the location of the trigger point, 
pain is felt in more than one location and may stay present for a period of time long after the 
stimulus has been removed from the original location. An example of this would be applying 
pressure to a trigger point in the rniddle of the upper trapezius fibers and noting how it may 
provoke pain in the back of the neck up to the occipitus ( the back of the head) and down to 
the shoulder and upper arm regions (Travel1 and Simons, 1999). 
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A trigger point is thought to develop from a muscle perfonning a single movement or a 
series of repeated movements leading to a contracture in the tissue (Simons, 2004). A 
contracture takes place when the muscle fibers have not return to a resting position but have 
remained in a shortened or contracted position. The trigger point is described as being a 
nodule-like structure attached to or resting within the muscle. The nodule structure is 
thought to occur because of thickening of muscle fibers. When the therapist palpates the 
nodular structure, a cord or rope-like formation is found underneath their finger tips (Davies 
and Davies, 2004; Mense and Simons, 2001; Travell and Simons, 1999). 
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Figure 3: Diagram of trigger point nodule (contraction knot) in a muscle (Adapted 
from Simons, 2004) 
In diagram 3, CTrP is defined as the contraction knot of the trigger point and ATrP is the 
active trigger point location on the muscle where the person would be experiencing pain. 
It is not uncommon for a trigger point ta be called a myofascial trigger point (Stecco, 2004). 
The name, myofascial trigger point, describes the tissue"fascia" that envelopes a muscle, 
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becoming adherent at the same location where a trigger point has developed (Figure 3). 
Fascia is known to be adherent at different points (Stecco, 2004) in the body. If the fascia 
was not adherent at different locations throughout the body, it would be continuously 
moving and become displaced. The location where the fascia is adherent to the muscle is 
often in close proximity to where potential trigger point nodules may develop. If a trigger 
. point nodule develops at the site where the fascia is adherent to the muscle the location will 
become thickened and less pliable potentially aggravating an underlying problem. This 
would be in contrast to no nodule developing at the location where the fascia is adhererit to 
the muscle or if the nodule develops in another location other than where the fascia adheres 
to the muscle (Stecco, 2004). The fascial adherence and the trigger point may lead to a 
common problem, the myofascial trigger point. 
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a,-motor nerve ~ 
Motor end plate region 
Figure 4 Diagram of the neuromuscular junction (adapted from McPartiand, 2004) 
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1.12 Why does a trigger point develop? 
A trigger point is thought to develop because of sorne form of dysfunction that takes place at 
either the presynaptic or the post synaptic end plate of the neuromuscular junction. The 
release of acetylcholine (ACh) across the neuromuscular junction allows for action 
potentials to occur and for a muscle contraction to take place (Guyton and Hall, 2000). An 
integrated hypothesis developed by Simons (2004) explaining the etiology of the myofascial 
trigger point, speculates that excessive levels of acetylcholine released from the presynaptic 
end plate to the post synaptic end plate c1eft may be one of the reasons why a trigger point 
develops. Simons along with Travell (1999) have done extensive investigation into the role 
of trigger points and pain over the last 40 years. 
Acetylcholinesterase, (AChE) is the enzyme that would normally breakdown the 
acetylcholine at the neuromuscular junction (Figure 4). When a problem occurs, sorne type 
of dysfunction may prevent the acetylcholinesterase from being released to break down the 
acetylcholine. As weil, the release of acetylcholine at the presynaptic deft (Point 1 in 
Figure 5) is dependent on the voltage-gated calcium Ca2 + channels (L-type and N' type) 
(Guyton and Hall, 2000) . If there is a defect/dysfunction of one of these Ca2 + channels 
there will be a continued release of acetylcholine (Simons, 2004). Thus, two mechanisms 
leading to a dysfunctional motor end plate causing muscle contracture may cause the 
development of trigger point nodules (Figure 3). 
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As mentioned above, dysfunction at the motor end plate may lead to a sustained contraction 
of muscle contraction. A sustained muscle contraction, as illustrated in Figure 5 (points 2 to 
6) will lead to compression of local sensory nerves, reduced local blood supply, decrease 
local supply of circulation oxygen and eventual energy crises within the tissue (Simons, 
2004). A resulting lack of ATP (Points 4 and 5' in Figure 5) may lead to impairment in the 
Ca2 + reuptake by the sacroplasmic reticulum, maintaining elevated cytoplasmic Ca2 + 
concentrations, which may continue contractile activity. As weil, the reduction in ATP may 
lead to an increase in chemicals (Point 5 in Figure 5) being secreted by the sustained muscle 
contractures that stimulate free nerve endings. These chemicals include bradykinin, 
cytokines, serotonin and histamine. This continued dysfunction rnay lead to sorne form of 
disorganization of the mitochondria. (Sirnons, 2004) 
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Figure 5: Theoretical model of the development of a trigger point (adapted from 
Simons, 2004) 
Different components of the integrated model put forward by Simons (2004) have been 
looked at by researchers using animal models. Hou et al., (2002) has looked at the raIe of 
calcium blockers and trigger points. Chen et al, (1998) has looked at the raIe of the 
autonomie nervous system and trigger points. Kuan et al., (2002) has looked at the raIe of 
excessive acetylcholine release and trigger points. Each of the studies has confirmed 
Simons's integrated hypothesis so far. 
At least three other structures may be found in tissue that are somewhat similar to a trigger 
point nodule and should be identified. These structures include: 1) calcification of tissue 
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leading to calcium deposits which are bone-Iike structures hard to the touch (myositis 
ossificans), 2) a fatty nodule (often seen in the low back) which is soft and pliable and 3) a 
ganglion which is closely linked to superficial nervous tissue. What differentiates the 
calcium deposit and the fatty nodule from a trigger point is the mobility of the structures. 
Both the calcium deposit and the fatty nodule have a slight mobility, and both structures may 
be moved in close proximity to where they are found. This is in contrast to a trigger point, 
which is not mobile and will remain in the same location until sorne form of intervention 
takes place (Davies C, Davies, 2004; Travell and Simons, 1992). A ganglion is similar to 
the trigger point in that it does not move, but the ganglion is more likely to be attached to a 
superficiaJ structure such commonly palpated around the anterior aspect of the distal 
forearm. The ganglion often does not elicit pain when palpated and a common therapeutic 
approach to remove the ganglion has been to quickly apply a compressive force to flatten the 
ganglion, or to have the ganglion surgically removed (Dumontier et aL, 2006) 
1.13 The rationale for investigating trigger points in this project 
A trigger point is often found near the mid point of the muscle in close proximity to the 
motor points of that muscle. Knowing that trigger point nodules are commonly used by 
c!inicians to interpret pain for their patients and having a general idea of where to locate a 
potential trigger point nodule on the muscle, it was deemed appropriate the same locations 
be used in this project. Also, knowing what is not considered a trigger point nodule gave the 
athletic therapists clear guidelines as ta what to look for when palpating the subjects. 
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1.14 Summary of literature review 
Pain in the upper arm, shoulder and neck are common problems after breast cancer 
therapy. 
Women seem to be at greater risk for developing shoulder and neck problems, but it is 
unclear whether it is because of their muscle composition in that region, the jobs that they 
are required to perform on a daily basis or, as in men, due to their lack of physical activity. 
The algometer has been used to quantify the subjective pain of an individual through the 
use of PPT values. PPT measured at the mid point of a muscle tends to be more consistent 
compared to other locations on the body. Studies that have used the algometers to evaluate 
pain have only recently taken into consideration the idea that a women's menstrual cycle 
may have an effect on the values obtained. 
Clinician's that work with people experiencing musculoskeletal pain believe that trigger 
point nodules found in the muscle tissue contribute to a patient's musculoskeletal problem. 
A number of charts have been developed and books written outlining the locations of 
potential trigger point nodules in the body. 
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1.15 Implementing the literature review into this protocol 
A hand-held algometer was used to give a quantifiable measure of pain in the upper arm, 
shoulder and neck region. The algometer was applied to the mid point of muscles where 
potential trigger point nodule rnay be located. The muscles that were to be tested were 
locations that are consistent with problematic areas associated with breast cancer surgery 
or cornmon musculoskeletal disorders. 
The protocol was to be first used with individuals who are not experiencing any 
musculoskeletal dysfunction as to limit the number confounding variables. A women' s 
rnenstrual cycle is known to influence her perception of pain. The subjects who were 
selected for the project would have to be pre rnenopausal, with regular menstrual cycles. 
(A decision to limit the number of confounding variables) Ali of the women participating 
in the study should be tested at the same stage of their menstrual cycle. 
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1.16 Main hypothesis for this study 
The main hypothesis of this study was: The application of the hand-held algometer to eight 
different locations in the upper arm and torso over four consecutive days of testing would 
show variation in pressure pain threshold values between the different locations on the same 
subject. It was expected there would be little or no variation in the pressure pain threshold 
values obtained between days. 
1. 17 Additional questions 
It was thought that the amount of adipose tissue an individual has at each of the 8 different 
locations may influence the PPT values that will be obtained. 
Additional question 1) we anticipated that a testing location with a higher skin-fold value 
would also have higher PPT values compared to a location with low skin fold value, on the 
same subject. 
We wanted to blind the data collector on whether a trigger point was present at the testing 
location. This required the use of two different therapists to identify the testing locations and 
to palpate for the presence or absence of a tIigger point at each location. 
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Additional question 2) We expected that there wouId be significant agreement (p< 0.05) 
between the two athletic therapists palpating for the presence or absence of a nodule at the 
testing location. 
Additional question 3) We expected that subjects that did have a nodule at a specifie 
location would have a lower PPT value when compared to a location that did not have a 
trigger point nodule on the same subject 
Pain is a complex problem that is very subjective and is perceived differently between 
individuals, this led to our last question, which has been answered in the literature and 
repeated in this study. 
Additional question 4) the PPT values that were collected were expected to vary for the 
same location between different subjects. 
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CHAPTERII 
METHODOLOGY 
2.01 Subject selection: 
Nineteen female subjects with a mean (± SD) age of 23.9 ± 5.2 yrs, mean height of 1.7 ± 0.1 
m, average weight of 64.6 ±10.3 kg and a mean body mass index of 23.6± 3.5 were recruited 
from the university community. To limit the number of confounding variables all subjects 
were non-smokers (Pauli et al., 1993) and were involved in some form of regular physical 
activity (van Amelsvoort et al., 2006). The forms of physical activity varied and included 
dance, running, swimming and martial arts. None of the subjects had experienced any 
shoulder pain or significant musculoskeletal pain that required medical review over the last 
6 months. Subjects were recruited for this study following approval of the University 
Ruman Research Ethics Committee at UQAM. Each subject was explained the risks of 
participating in this study and voluntarily gave their written informed consent. (Annexes 1 
and 2) 
The subjects were asked not to undertake any new physical activity over the four day testing 
period. New physical activities were defined as activities that the subjects had not performed 
routinely for an extended period of time (for example, weight training after a prolonged 
period of inactivity). The ingestion of caffeine has been found to alter a person's perception 
of pain so subjects were also asked to avoid ingesting any caffeine products (Galeotti et al., 
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2002) for at least 4 hours prior to each testing period. Subjects were asked to avoid any 
analgesic medication throughout the entire 4-day experimental period. 
2.02 The calibration and application of the algometer: 
Calibration: The algometer was calibrated at the onset of each day of testing, before being 
applied to the subject. The algometer (Somedic Sales AB; Model type 2, Sweden) was 
calibrated using a standard protocol that is recommended by the manufacturer. The protocol 
requires that the algometer be placed on to a stable surface; we used a table top, with the 
nozzle surface facing upwards. A one kilogram weight (provided by the manufacturer) was 
applied to the O.Scm diameter applicator head attached to the end of the nozzle. Values were 
obtained and recorded from the LeD display of the algometer. The acceptable calibration 
values ranged from 98 to 102 kilopascals. This would mean a potential 4% error in the 
recorded values. The calibration process was repeated 3 times and values would have to fall 
within the expected range. When the values did not fall within the acceptable ± 2 kilopascal 
range the algometer was restarted and the calibration process was repeated. 
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2.03 Application: 
After following the manufacturer's calibration guidelines, the O.Scm applicator head was 
replaced following calibration with the 2cm applicator head to measure PPT's. The 2cm 
applicator head was used because we were concemed about future projects working with 
patients undergoing adjuvant therapy for breast cancer. We felt that a smaller applicator 
head being applied to testing locations on these future subjects (dealing with breast cancer) 
may place them at an increased risk of bruising and localized tissue trauma. This may 
heighten their concem about developing Iymphedema, a significant problem for this 
population (McCredie et al., 2001). A second point is that the 2 cm applicator appears to 
give indication of local pain sensation when compared to smaller applicator heads 
(Takahashi et al., 2005). 
The testing locations were identified through the placement of marks on the skin; over two 
(2) anterior locations and six (6) posterior upper torso locations (see Figures 6-13). The 
marks served to identify the appropriate location in which to place the nozzle of the 
algometer. The experimenter applied the algometer to each of the eight locations in the 
following sequential manner (i.e., 1 through 8): 1) the mid-point of the muscle fibers of the 
long head of biceps, figure 6, 2) the mid-point of the ariterior fibers of the deltoid figure 7,3) 
the mid-point of the muscle fi bers of the lateral head of the triceps figure 8, 4) the upper half 
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of the fibers of the rhomboids major figure 9, 5) the mid-point of the posterior fibers of the 
deltoid figure 10, 6) the proximal one-third of the fibers of the supraspinatus (the location 
closest to the medial border of the scapula) figure 11, 7) the upper fibers of the trapezius 
(medial to the superior angle of the scapula), figure 12 and 8) the distal one-third of the 
muscle fibers of the infraspinatus figure 13. The specifie locations were selected for one of 
the three following reasons: 1) the location has been used in a previous study such as the 
trapezius, deltoid and infraspinatus (Galeotti et al., 2002; Jensen, Pilegaard and Sjogaard, 
2000; Lindman et al., 1991); 2) the location is often identified in a clinical setting as being 
problematic such as the rhomboid and supraspinatus (Brandt et al., 2004; Bunn et al, 2006; 
Ge, Madeleine and Arendt-Nielsen, 2005), and 3) the biceps and triceps were found to be 
frequently painful following breast surgery with an axillary node dissection for breast 
(McCredie et al., 2001). 
The location selected on the muscle was based on the possibility of a trigger point nodule 
being present at the site. Sorne muscles had multiple locations where a trigger point nodule 
may be located. We tried to have 8 distinct locations to avoid any confusion in the testing 
protocol. Confusion may have arisen in the sites where 2 or more trigger point locations may 
be in close proximity, such as infraspinatus/rhomboids and trapezius/ supraspinatus (Falla 
and Farina, 2005). No location tested on the 19 subjects had an active trigger point. An 
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active trigger point being defined as causing pain and restricting mobility. A subject who 
would have had an active trigger point nodule would have been removed from the project. 
The subject was placed in a supine position and then a prone position for the application of 
the algometer. The 2 positions allowed for better stabilization of shoulder and torso 
compared to a seated position. With the subject in the supine position, the algometer was 
applied to the anterior aspect of the shoulder and arm for the PPT measurement over the 
marks located on the anterior deltoid and bicep. With the subject in a prone position, the 
algometer was applied to the posterior aspect of the arm (triceps), shoulder (posterior 
deltoid) and torso (infraspinatus, supraspinatus, rhomboids and the trapezius) for the 
measurement of PPTs. Pillows and padding were used to support the subject's shoulder and 
arm when appropriate. The total time required to a collect 3 complete sets of data for each 
subject (4 trials total) was approximately 25 minutes. This time included the changing of 
position of the subject (8 tiines total supine-prone- supine) as weil as the set up and 
stabilization of the shoulder. This worked out to approximately a 5 minute rest time between 
applications of the algometer at each location. 1t was decided not to randomize the order of 
application to minimize the amount of unnecessary movement by the subject and to have a 
consistent time interval between each location. 
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2.04 Experimental Procedures 
Practice session: Before the data collection process began a pilot project was completed 
that tested 8 different locations on 5 subjects. The goal of the pilot project was to familiarize 
the evaluator with the aIgometer and to identify any potential problems. 
Starting time for subjects: The subjects' first day of testing occurred within four days after 
last day of the subject's menstrual cycle. The subjects were tested over four consecutive 
days. Each testing session took place in the moming at approximately the same time of day, 
over each of the four days. 
Testing schedule: An initial trial was performed at the outset of each testing session to 
farniIiarize the subject to the testing procedure. The data from this trial was discarded. 
Thereafter, three complete sets of data were collected on the subject. A complete set of data 
included applying the algometer to each location (l through 8 in sequence) and recording the 
values obtained from the location. This order of measurement was done two more times. 
Each trial (of ail 8 locations) was recorded on a single data sheet. When the data sheet was 
completed, the sheet was removed from view of the experimenter, so that subsequent data 
sets were collected without bias. This procedure was repeated for each trial over the four 
consecutive days. 
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2.05 Determination of the PPTs: 
At the beginning of each testing session, the subject was reminded that the PPT was defined 
as the "instant or moment that the pressure on the skin surface changed from the sensation of 
pressure to the sensation/perception of pain". The experimenter explained to each subject 
that they would feel a graduaI increase in pressure on the skin. The pressure would continue 
to increase until the subject experienced a sensory transition from pressure to pain. The 
experimenter explained to each subject that the trial at a specifie location would end if and 
when the readings went beyond 400 kilopascals. This precautionary measure served to 
avoid any unnecessary pain or damage to the skin and underlying structures. The 
experimenter applied the nozzle of the hand-held algometer at each landmark location at an 
approximate rate of 30 kilopascals per second. The increase in the force applied to the skin 
surface was viewed by the experimenter, via the digital output display on the algometer. The 
experimenter continued to apply pressure until the subject pressed the button on hand-held 
switch indicating that they perceived a sensory transition from pressure to pain. Thé subject 
never viewed the recorded values. 
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2.06 The locations that were tested 
Biceps brachii trigger point 
The trigger point location of the long head of biceps brachii was identified by moving in a 
caudal direction from the bicipital groove of the humerus, to the upper one half of the biceps 
muscle. At the mid point of the muscle a small mark was made on the skin surface. 
/ 
Figure 6: Long head of the biceps trigger point location 
(Adapted from Davies and Davies, 2004) 
49 
Anterior deltoid trigger point 
The anterior fibers of the deltoid muscle trigger point location were located by finding the 
most lateral aspect of the acromial cavicular joint. The athletic therapist then moved in an 
anterior and inferior direction, to the upper 1/3 of the anterior fibers of the deltoid using the 
deltoid tuberosity of the humerus as a distal reference point. 
Figure 7: The anterior fibers on the deltoid trigger point location 
(Adapted from Davies and Davies, 2004) 
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Triceps Brachii trigger point 
The trigger point location on the triceps brachii was identified by moving in a cranial 
direction from the most proximal aspect of the olecranon process of the ulna. The upper haIf 
of the lateral head of the triceps was marked. 
Figure 8: The lateral head of the triceps trigger point location 
(Adapted from Davies and Davies, 2004) 
51 
Rhomboids major trigger point Location 
The trigger point location for the rhomboids major was identified by locating the spine of 
the scapula and moving slightly medial and inferior. The spine of the scapula attaches to the 
3rd thoracic vertebrae, moving in a caudal direction to the mid point between the scapula and 
the spine, at the level of T3 the trigger point was marked. 
Figure 9: The rhomboids major trigger point location 
(Adapted from Davies and Davies, 2004) 
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Posterior deLtoid trigger point 
The posterior fibers of the deltoid muscle trigger point location were found by locating the 
most lateral aspect of acromial cavicular joint. The athletic therapist then moved in a 
posterior and inferior direction to the upper 1/3 of the posterior fibers of the deltoid. The 
deltoid tuberosity of the humerus also served as a distal reference point for this landmark. 
Figure 10: The posterior fibers on the deltoid trigger point location 
(Adapted from Davies and Davies, 2004) 
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Supraspinatus trigger point (Davies C, Davies, 2004) 
The trigger point location of the supraspinatus was identified, by locating the spine of the 
scapula and moving slightly superior. Identifying the medial border of the scapula and 
moving lateral. The location of the trigger point would be in the medial third of the muscle. 
Figure 11: The supraspinatus trigger point location 
(Adapted from Davies and Davies, 2004) 
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Upper fibers of the Trapezius trigger point 
The trigger point of the trapezius was identified, by locating the spine of the scapula and 
moving in slightly superior and media!. The 6th and 7 th cervical vertebrae were also located. 
To differentiate between the two structures the 6th cervical veltebrae moved antel;or when 
the neck was moved into extension while the i h cervical vertebrae stays fixed in position. 
Figure 12: The trapezius trigger point location 
(Adapted from Davies and Davies, 2004) 
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Infraspinatus trigger point 
There are three different bony landmarks on the scapula to locate the appropriate trigger 
point on the infraspinatus. The trigger point of the infraspinatus was identified by locating 
the spine of the scapula and moving inferior and lateral from the medial border of the 
scapula and slightly superior from the inferior angle of the scapula. The trigger point was 
marked as being in the middle of the muscle in close proximity to the inferior angle. 
Figure 13: The infraspinatus trigger point location 
(Adapted from Davies and Davies, 2004) 
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2.07 The use of bony land marks as reference points 
The use of bony landmarks as anatomical reference points was thought be the most 
appropriate method to identify the locations in the upper extremity and torso region. The use 
of a bony reference point is a common technique used by c1inicians to locate anatomical 
structures due to the tremendous variability in body composition. Students enrolled in 
athletic therapy and physical therapy classes at Universities are taught this skill in their first 
year and expected to become competent in this area throughout their academic study. The 
two athletic therapists who were used for this project presently work at Concordia 
University in the Department of Exercise Science teaching these manual skills to students. 
In sorne studies the use of callipers and tape measures may be appropriate to assess body 
composition. For this project it would have been impractical to measure a specific distance 
with a tape measure because of the number of locations in and around the scapula. The 
scapula thoracic region is often referred to as the fourth joint in the shoulder (Mcgee, 2002), 
because of the significant amount of movement that takes place. In a resting position, the 
scapula's position relative to the spinal column is quite variable, this may include it being 
adducted, abducted elevated, depressed, the inferior angle being lateral rotated, the inferior 
angle being medially rotated as weil as combinations of the previously mentioned positions 
(Kendall, McCreary and Provance, 2005). Using a tape measure to a specific distance on 
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individuals with different body types and various scapular thoracic positions would have 
lead to a significant increase in errors. 
A second method used by Messing and Kilbom 2001, would have involved taking an 
impression of the joint surface. This technique has been used very effectively on the palmar 
surface of hands and the plantar aspect of the feet. The limitation with this technique for our 
project is the shape of the area being evaluated. Testing locations anterior and posterior on 
the torso and upper extremity would have required sorne form of marking solution placed on 
a very large portion of the skin surface of the subject. This would have required the subjects 
to disrobe to expose the upper back and the arm shoulder region. This would have increased 
the difficulty in recruiting subjects and when the subject had been recruited, potentially 
soiling the subjects clothes with the marking solution. It was thought that this approach 
would not have added significantly to the testing procedure except for an additional mess to 
clean up, eventually making the methodology more cumbersome. 
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Figure 14: Testing locations identified by pen marks (X) on the anterior surface of the 
upper arm and shoulder. 
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Figure 15: Testing locations identified by pen marks (X) on the posterior surface of the 
upper arm and shoulder. 
Please note from the angle the picture (Figure 15) was taken it may appear that the indelible 
mark is over the middle portion of the deltoid when in fact the mark is over the posterior 
fibres of the deltoid. The subject in the photo also has a slight rounding of the shoulders 
which may also lead to a misperception of the testing location. 
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2.08 Skin fold measures 
Within one week of the algometer testing, skin-fold measures were taken on each of the 
subjects to note the body fat thickness at each of the eight testing locations. The skin fold 
measures were applied following the American College of Sports Medicine guidelines 
(2006). Two data colleetors were required to correctly apply the skin calipers because of the 
unique locations being assessed. One data collector would pre-fold the skin location to be 
measured, with the ink mark being in the mid point of the fold. The second data collector 
would apply the skin fold caliper. 
Measures for the skin-folds were taken following the sarne sequence as with the algometer. 
Following the American College of Sports Medicine guidelines (2006), two complete sets of 
skin fold measures were obtained at each location. The second set of values obtained at each 
location had to be within 10% of the first measure. If the difference between the first and 
second measures was greater than 10% then a third measure at that location would be taken. 
At that point, the first set of data obtained at that location wouId be discarded. 
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2.09 The skin-fold measures for the eight locations 
The locations that were selected for this project are not sites that are commonly used when 
assessing body composition. Therefore it was considered important to include a detailed 
outline of the procedure at each site. 
The skin fold for the long head of the biceps required that a pre-fold of the skin be made in a 
cranial-caudal direction (superior-inferior direction). The ink mark, indicating the place 
where the algometer had been applied, was at the mid point of the fold. 
The skin-fold for anterior deltoid required that a pre-fold of the skin be made following the 
direction of the muscle, moving in a medial superior direction to a lateral inferior direction. 
The ink mark, indicating the place where the algometer had been applied, was at the mid 
point of the fold. 
The skin fold for lateral head of the triceps required that a pre-fold of the skin be made in a 
cranial-caudal direction (superior-inferior direction). The ink mark, indicating the place 
where the algometer had been applied, was at the mid point of the fold. 
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The skin fold for rhomboids major required that a pre-fold of the skin be made in a cranial­
caudal direction (superior-inferior direction). The ink mark, indicating the place where the 
algometer had been applied, was at the mid point of the fold. 
The skin fold for posterior deltoid required that a pre-fold of the skin be made following the 
direction of the muscle moving in a medial superior direction to a lateral inferior direction. 
The ink mark, indicating the place where the algometer had been applied, was at the mid 
point of the fold. 
Supraspinatus required that a pre-fold of the skin be made following the direction of the 
muscle; moving in a medial direction to a lateral direction. The subject was advised to 
maintain their posture in an anatomically neutral position. If the head was in a f01ward 
flexed position then the tissue was under to much tension to secure the tissue. The ink mark, 
indicating the place where the algometer had been applied, was at the mid point of the fold. 
Trapezius a pre-fold of the skin was required, crossing to the opposite side of the spinal 
column moving in a medial direction to a lateral direction and pre-folding the right and left 
portions of the upper trapezius. The subject was advised to maintain their posture in an 
anatomically neutral position. If the head was in a f01ward flexed position then the tissue 
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was under to much tension to secure the tissue. The ink mark, indicating the place where the 
algometer had been applied, was at the mid point of the fold. 
Testing of the infraspinatus required that a pre-fold of the skin be made following the 
direction of the muscle in a cranial-caudal direction (superior- inferior direction). The ink 
mark, indicating the place where the algometer had been applied, was at the mid point of the 
fold. 
It was speculated that with the tissue adherence to the underlying fascia, that with repeated 
pre-folding and measuring of the tissue that each of the testing location would be less 
adherent and would eventually loosen up making it easier to apply the test. No subject was 
measured more than 3 times at any location. 
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2.10 Break down of tasks performed by individuals in the research project 
Three additional individuals were required to help the M.Sc. candidate complete the project. 
It is important to briefly summarize what their tasks entailed. 
The two athletic therapists 
1.	 Identified and marked the eight different locations on each subject. 
2.	 Palpated each location for the presence or absence of a nodule associated with a 
tligger point, before the algometer was applied on day 1 and after the algometer had 
been applied on day 4. 
Data collector number 2 
1. Applied the skin fold calipers to each of the testing locations of each subject. 
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Data collector number 1, the M.Sc. candidate 
1.	 Recruited subjects, secured signed consent forrns from each subject, and organized 
the appropriate starting times for each subject. 
2.	 Calibrated the algometer before each testing period. 
3.	 Applied the algometer to each of the locations on ail subjects over the 4 days of 
testing, as weil as recorded ail measures. 
4.	 During the skin fold measurements, prefolded the skin at each location so that the 
skin-fold calipers could be applied correctly, as weil as recorded ail measures. 
5.	 Perforrned the analysis of ail data. 
6.	 Wrote up the thesis and papers that were submitted 
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2.11 Statistical analysis: 
Descriptive analysis of aIl data was performed using Microsoft Excel (Microsoft, Redmond, 
WA) to report results as mean ± S.D. Significant differences between means were detected 
by using SPSS version 11.5 (SPSS Inc., Chicago IL). A repeated measures analysis of 
variance was performed evaluating the absolute changes in PPT at each location throughout 
the 4 consecutive days of testing. A post hoc analysis was performed using a Tukey test. The 
criterion for significance was set at p :S 0.05. Inter class correlation (lCC) scores were 
calculated for the PPT values coIlected at each location on each day of testing. 
A repeated measures analysis of variance was performed evaluating the differences in skin 
fold values obtained at each location. A post hoc analysis was performed using a Tukey test. 
The criterion for significance was set at p:S 0.05. 
A regression analysis was performed between the skin fold values and the PPT values 
obtained at each location. The criterion for significance was set at p :S 0.05. 
Interclass correlation was performed on the consistency of the two athletic therapists 
detennining whether a nodule was present at of each of the 8 locations. The interclass 
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correlation evaluated the status before and after testing. The criterion for significance was 
set at p ~ 0.05. 
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CHAPTERIII 
MANUSCRIPT NU1VIBER 1 
3.01. Overview of the accepted manuscript 
What follows is a copy of the manuscript that was accepted in the Journal of Pain and 
published in August 2007, Volume 8, number 8 
Following the department of kinanthropologie guidelines concerning publications and 
graduate students, Dr. Alain Comtois, PhD and supervisor to the M.Sc. candidate is listed as 
the corresponding author with the editor to the Journal of Pain. The work submitted to the 
Journal of Pain is the work of ML David H. Jones. Both Dr. Comtois and Dr. Kilgour made 
significant comments on the manuscript. 
The results of this paper were a surprise to the candidate and to his supervisors. It was 
expected that there would be !ittle or no change in pressure pain threshold values over the 4 
days of testing. When deciding to submit this paper for publication it was felt that the results 
would be of interest to fellow researchers, because it is contrary to what has been seen in 
other studies. 
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3.02 Methodology paper . Letter of acceptance 
-----Message d'origine----­
De: The Journal of Pain [mailto:jpain@jpain.us] 
Envoyé: April 20, 2007 8:02 AM 
À : Comtois, Alain Steve 
Objet: Your Submission JPAIN-D-06-00253Rl 
Ms. Ref. No.: JPAIN-D-06-00253Rl 
Title: Test-retest reliability of pressure pain threshold measurements of the upper limb and torso in young 
healthy women The Journal of Pain 
Dear Professor Comtois, 
Thank you for submitting "Test-retest reliability of pressure pain threshold measurements of the upper limb 
and torso in young healthy women" to The Journal of Pain. l am pleased to say your manuscript has been 
accepted for publication. 
Prior to publication, you will receive page proofs from Elsevier Science, which publishes The Journal for the 
American Pain Society. Proofs are made available to you electronically, in PDF file format. You will receive 
notification via e-mail. 
Thank you for submitting this interesting paper. 
Sincerely yours, 
GF Gebhart, PhD 
Editor-in-Chief 
The Journal of Pain 
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3.03 Letter to the editor concerning revisions to manuscript 
March 14,2007 
Dear Dr. GF Gebhart, PhD 
Eclitor-in-Cruef 
The] ournal of Pain 
RE: ]Pain-D-06-00253 
Dear Dr. Gebhart, 
Thank you for assigning the 2 reviewers to examine and to comment on our manuscript 
entitled "Test-retest reliability of pressure pain threshold measurements of the upper limb and 
torso in young healthy women" l have made ail the recommended 
changes/corrections/clarifications that have been suggested by the reviewers. l have included 
the reviewer's comments and have rughlighted where the changes have been made. 
Major comments and replies: Reviewer # 1 
1) It is not clear why only one evaluator is used. If the authors planned to show the intra-tester 
reliability of PPT measurement, blinded multiple evaluators should be used to increase its 
reliability. 
Reply to comment #1: The goal of our study was to measure PPT stability over 4 days. Hence, 
the importance of having one single evaluator performing ail of the measurements, at trus 
moment we are not interested in inter-tester reliability, wruch has been weil established by 
others (e.g., Persson et al, 2004). 
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This is now stated clearly in the abstract on page 2 where the opening sentence has been 
changed to: The goal ofthis stuefy was to test re-test the intra and inter dqy reliabiliry. It is also stated 
clearly in the introduction on at the bottom of page 3 under the heading objectives and reads 
as foilows: Thus, the objectives ofthis stuefy are 1) establish the intra-tester reliabiliry and reproducibiliry 
measures ofPPTs with the use ofa hand-held algometer by a single evaluator; and 2) to evaluate the reliabiliry of 
the algometer in determining the PPT values in women over 4 conseCtitive dqys oftesting. This should clarify 
for the reader that we are looking at the rel.iability over a number of days. 
Reference: Persson AL, Brogargh C, Sjolund BH: Tender or not Tender: Test -Retest 
repeatability of pressure pain thresholds in the Trapezius and the Deltaid muscles of healthy 
women, J Rehabil Med 36:17-27, 2004 
2) Why the order of PPT measurements at 8 points was not randomized? 
Randomization is only possible method to reduce order bias in this case. 
Reply to comment #2: We agree with the reviewer that perhaps randomizing the order of 
application would have made for a stronger research design. However, logisticaily or clinicaily 
randomization would complicate performing measurements. The rationale for not randomizing 
in our study is as follows: The order of application of the algometer to the 8 locations was based 
on minimizing the amount of unnecessary movement. It is expected that this template will be 
used on groups of women who have neck, shoulder and upper arm problems. It was decided 
that testing of ail of the anterior locations should be done first and then the subject would turn 
over to a prone position for ail the posterior location measurements. With 4 trials of 
measurements at each location the subjects were required to turn from supine to prone or 
prone to supine 8 different times during the testing period. Randomization would have made 
the measurements extremely tedious for the subjects. Also, by randomizing the location sites, 
we would lose control of the time taken between PPT measurements on any particular day. 
A paragraph in the methods section was added ta outline this rationale in the 3rd paragraph 
on page 6 and reads as follows: Ali sul:jects were placed in a supinepositionfor the measurement ofthe 
bicep and anterior deltoid and then moved to the proneposition for the measurement ofthe remaining sites. These 
two positions allowedjor belter stabilization ofthe arm, shoulder and torso compared to the seatedposition. We 
elected to jollow this sequential order ofmeasurement as opposed to randomizjng the locations for PPT 
measurements in order to eliminate repeated movements between the strjJine to prone positions. Thus, with the 
subject in the strpine position, the algometer was applied to the antmor aspect ofthe shoulder and armfor the 
PPT measurement over the marks located on the anterior deltoid and bicep. With the sul!/ect in aprone position, 
the algometer was applied to theposterior aspect ofthe arm (triceps), shoulder (posterior deltoid) and torso 
(injraspinatus, supraspinatus, rhomboids and the trapezjus) for the measurement ofPPTs. Pillows andpadding 
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were used to support the su!?ject's shoulder and arm when appropriate. The total time required to collect three 
complete sets ofdata for each su!?ject (4 trials toia/) was approximate/y 20 minutes. 
3) What is measured by the algometer and what is expressed by the PPT value? 
Reply to comment #3: In the introduction, on page 3, we have clarified what is an algometer 
and what is being measured. 
The following sentences have been added and read as follows: .. .within the a/gometer. The 
progressive development ofpressure, I?J the application ofthe a/gometer head, produces agraduai 
displacement/ depression ofthe local skin surface. The PPT is thepoint Ivhere the amount ofpressure being 
app/iedproduces a local sensory shiftfrom pressure to pain. According to Nie et al. .. 
4) Some loci (S4, S12) clearly decreased (Figure 6) and they strongly affect the mean value, so 
regional difference should be more stressed in the discussion. 
Reply to comment #4: We now stress this issue in both the results and discussion sections. 
In the results section, page 9, the last paragraph before the discussion, we have indicated that 
there are at least 3 non-followers (Sl, SB and S15) that do not conform to the general trend of 
the 19 subjects. 
The text in the results section now reads as follows: Figure 4 represents ail PPT values obtained at 
location 4 (rhomboids) for ail 19 su!?jects. The thick fine andpoints represent the mean ± 5D for each trial and 
every suiject and is in fact the fine oflocation 4presented in Figure 3. The data trend and dispersion shown in 
Figure 4 is representative ofdata collected at ail 8 locations. Note, however, that there are three su!?jects (51, 513 
and 515) that do notfollow the overall trend. In the remaining 16 suijects, four suijectsfo//ow the overall trend 
except on dqy 4 where the PPT values continued to decrease. The individual PPT values are illustrated in Fig 4 
and are expressed numerical/y as means and standard deviations in Table 3. 
The discussion section on page 13, paragraph 1, has been modified ta stress this regional 
difference and now reads as follows: This repeated noxious stimulation has been shown to cause central 
neroous system changes 14. In fact, Treede et aF have investigated brain corticalprocessing ofpain I?J using both 
PET scan andJMR1 imaging and have shown the involvement ofthe thalamus, the primary somatosensory 
cortex (51), the secondary somatosensory cortex (52), the insula,forebrain and the cingu/ate cortex (GC). These 
areas have been suggested to encode aJfective motivationalpain aspects (GC andforebrain), whereas the lateral 
system (51 and 52) is more /ike/y to accountfor the sensory discriminative pain dimension}2. It is dear that in 
our stutfy apainful response was beingprovoked repeated/y not on/y on one dqy, but over 4 consecutive dqys. It is 
unc/ear lvhether there lvas sufficient stimulation to cause someform ofphysiologica/ adaptation. Nonethe/ess, this 
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mqy accountfor some ofthe variabiliry that takes place as shown È!Y the nonjollowers (51J 513J and 5 15) in 
figure 4. 
Please note that chatt listed as figure 6 is now listed as figure 4 
5) In conclusion, the author assumed the reduction of PIT due to local micro trauma or central 
response, however it is not weil explain the data that the changes of PIT were clifferent in each 
points and not uniformly reduced (Figure 6). 
Reply to comment #5: In the results section we have inclicated that 3 of the subjects clid not 
foilow the trend of decreased PPT values over 4 consecutive days of testing. In the remaining 
16 subjects 4 of the subjects had an increase in PIT values between days 3 and days 4. Page 9 
last paragraph in the results section 
Page 9 last paragraph in the results section 
The following section has been changed: 
Changes in absolute PIT measurements over 4 consecutive days 
The data outlined in Table 2 show a significant main effect of time (Fm p<ü.ü5) between days 1 
and 4 over ail eight locations. 
With reference to chart 1, a significant lowering of PIT values is seen from day 1 ta ay 2, across 
ail 8 locations. The PIT values remain significantly lower across ail 8 locations on day 3, when 
compared to day 1. On day 4, there was a general trend taward the increase in PPT values 
across ail 8 locations; however they ail remained significantly lower than day 1 values. 
Chatt 2 is a graphic representation of ail the PIT values obtained at location 4 (rhomboids) for 
ail 19 subjects. The thicken line and points represents the mean value for each trial. The data 
shown in chatt 2 is typical of the data coilected at ail 8 locations. 
This section now reads 
Changes in absolute PPT measurements over 4 consecutive days 
The data outlined in Table 2 show a signiftcant main effect oftime (F2.77p<O.05) between dqys 1 and 
4 over ail eight locations. 
Figure 3 shows a signiftcant lowering ofPPT values seen on dqys 2J 3J and 4 across ail 8 locations 
when compared to daY 1. On dqy 4J thm was ageneral trend towards an increase in PPT values across ail 8 
locations; however thi)! ail remained signiftcantfy lower than dqy 1. 
Figure 4 represents ail PPT values obtained at location 4 (rhomboids) for ail 19 subjects. The thick line 
andpoints represent the mean ± 5D for each trial and every suiject and is inlact the line oflocation 4 presented 
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in Figure 3. The data trend and dispersion shown in Figure 4 is representative ofdata collected at ail 8 
locations. Note, however, that there are three su!:?/ects (51, 513 and 515) that do notflllow the overall trend. In 
the remaining 16 su!:?jects, fOur suqectsfollow the olJerall trend except on day 4 where the PPT values continued 
to decrease. The individual PPT values are illustrated in Fig 4 and are expressed numerical(y as means and 
standard deviations in Table 3. 
6) Figures 1-4 are not so much informative so it is better to give schematic illustration in one 
figure including the algometer. 
Reply to comment #6: We have removed figures 1 and 2 from the previous version and we 
have retained figures 3 and 4, which give an accurate representation of many of the testing 
locations as weil as how the algometer was applied. The charts that were previously listed as 
figures 3 and 4 are presently listed as figures 1 and 2. We have also retained figures 5 and 6 
from the previous version and listed them as figures 3 and 4. 
Minor comments and replies: Reviewer 1: 
1) The significant digit should be considered in ail expression of values (ages, 1CC, etc). 
Reply to comment #1: Ail age, height, weight values are represented as whole numbers with 
one decimal place. The 1CC values have been changed to have two decimal places. 
2) The authors stated that 1 kilogram weight was put on the head of algometer and confirmed 
the value between 98 ta 102 kilopascals. 1s this description correct? The linearity of algometer is 
also important information. It is better ta add some data of its linearity if it is available. 
Reply to comment #2: Additional detail has been included in the methods sections that 
outlines the manufactures recommended calibration guidelines. This detail is presented at the 
bottom of page 4 and at the top of page 5 
The following section has been changed Calibration: The algometer was calibrated 
at the onset of each day of testing, before being applied ta the subject. The algometer (Somedic 
Sales AB; Model type 2, Sweden) was calibrated using a standard protocol recommended by the 
manufacturer. The algometer was placed on to a stable surface, with the handle of the 
algometer on a table top with the nozzle surface facing upwards. A one kilogram weight was 
applied to the O.scm diameter applicatar head attached to the end of the nozzle. Values were 
obtained and recorded from an LCD display. The acceptable calibration values ranged from 98 
to 102 kilopascals. 
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This section now reads The algometer JJJas calibrated at the onset of each dqy of testing, bejore being 
applied to the su!?ject. The algometer (Somedic Sales AB; Model type 2) Sweden) 
was calibrated using a standardprotocol that was described and recommended I?J the manufacturer. The protocol 
required that the algometer be placed on to a stable suiface; we used a table top} with the nottle suiface facing 
upwards. A one kilogram weight that was provided I?J the manufacturer was applied to the 0.5cm diameter 
applicator head attached to the end ofthe noz'.{je. Values were obtained and recordedfrom an LeD displqy. The 
acceptable calibration values ranged from 98 to 102 kilopascals. When the values did not fall within this 
acceptable range (± 2 kilopascals) the algometer was restarted and the calibration process was repeated 
Unfortunately there is no available data on the linearity of the application of the algometer. 
3). A 2cm applicator head was used but the details were not clear. Its material and shape are 
important and the reason why 2cm was used instead of usual 1cm head in the previous 
literatures should be mentioned. 
Reply to comment #3: The project used the 2cm applicator head. We used the larger applicator 
head in the project because we were concerned about future projects working with patients 
undergoing adjuvant therapy for breast cancer. We felt that a smaller applicator may place these 
subjects (dealing with breast cancer) at an increased risk of bruising and localized tissue trauma, 
increasing their concern for developing lymphedema. 
The following section has been changed Application: The O.Scm applicator head was 
replaced following calibration with the 2cm applicator head to measure PPT's at the locations 
described below. 
This change has been made on page 5 paragraph 2 in the methods section 
This section now reads: Application: The 0.5cm applicator head (circular disc with a 
rubberize tip) was replacedfollowing calibration with the 2.0cm applicator head to measure PPT's. The 2.0cm 
applicator head (circular disc with a rubberize tip) was used as opposed to the smaller head becat/se we Jvere 
concerned about an increased risk of bmising and localized tissue trauma. In addition, there is evidence that the 
2.0 cm applicator appears to give indication oflocalpain sensation when compared to smaller applicator heads JI. 
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The Takahashi article suggested by this reviewer actually recommends using larger application 
heads with the algometer. A larger applicator head gives a better indication of pain for the 
subjects (compared to smaller applicator heads). We thank the reviewer for this insight. 
4) Sites of PPT measurements are important. Inter-subject variation might be large if there are 
any tender points or trigger points. There was no description of the nature of the loci used. 
Reply to comment #4: The locations that were selected for the testing template were chosen 
because they were identified as possibility having a trigger point nodule at the site. The locations 
were referred to in several texts that are popular with clinicians. The muscles selected were areas 
that were used in previous studies. The location on the muscle was chosen based on the 
possibility of a trigger point nodule at the site. Sorne muscles had multiple locations where a 
trigger point nodule maybe located. We tried to have 8 distinct locations to avoid any confusion 
in the testing protocol. Confusion may have arisen if the sites were in to close proximity with 
each other such as with location 8 infraspinatus and location 4 on the rhomboids. 
We have clarified this in the methods section of page 6, 2nd paragraph 
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This section has now been added: The locations on the muscle lvere chosen based on the possibiliry ifa 
trigger point nodule on the diJferent sites. We recognized that a potential trigger point nodule mqybe at the 
locations and we will be presenting that data in a companion paper. We can report that no location tested on the 
19 suf!jects had an active trigger point. An active trigger point being defined as caming pain and restricting 
mobiliry "ftr"'''. A'!)' suiject with an active triggerpoint nodule would have been removedjrom this stucjy. 
5) The measurements were done in sequential manner. PPT measurement might be affected by 
the previous measure. Ir should be stated why the order of measurements did not randomized. 
Reply ta comment #5: Randomizing the order of application would have made for a stronger 
research design. The order of application of the algometer to the 8 locations was based on 
minimizing the amount of unnecessary movement. Ir is expected that this template will be used 
of groups of women who have neck, shoulder and upper arm problems. It was decided that 
testing of ail of the anterior locations should be done, then the subject would turn over to a 
prone position and ail of the posterior locations were tested. With 4 trials at each location the 
subjects were required to turn from supine to prone or prone to supine 8 different times or the 
testing period. 
A paragraph in the methods section has been add outlining this rational, 3rd paragraph on 
page 6 
This section has now been added: Ali suijects were placed in a supine position for the measurement Of 
the bicep and anteriiJr deltoid and then moved to the prone position jor the measurement of the remaining sites. 
These Iwo positions al101vedjor better stabilization of the arm, shottlder and torso compared to the seatedposition. 
We elected to jollow this sequential order of measurement as opposed to randomi'{jng the locations jor PPT 
measurements in order to eliminate repeated movements between the supine to prone positions. 
6) The intervals of each measure were also important information but it did not mention. 
Reply to comment #6: Ir would take approximately 5 minutes to go through one complete set, 
considering set up, movement and recording of data. It would have taken a total of 20 minutes 
to coilect the 3 sets of data; the first set of data was not recorded. (300sec/8 locations =37.5sec 
per location) 
This inform has been added to the methods section at the top of page 7, it took appropriately 
20 minutes to complete all of the testing of 3complete data sets ( 4 sets total). 
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This sentence has now been added: The total time required to collect three complete sets ofdata fOr each 
suiject (4 trials tota~ was approximate/y 20 minutes. 
T) They stated cut-off of 400 kilopascal but several data indicate over 400 kilopascal. 
Reply to comment #7: ActuaUy only one individual had values over 400 kilopascals, actuaUy aU 
of her values were over 400 kilopascals 
This terrnination point was used as a safety precaution as outlined in the methods section, at 
the top of page 8 
The following section has been changed The experimenter explained to each subject 
that the trial at a specific location would end if and when the readings went beyond 400 
kilopascals. This cut-off served to avoid any unnecessary pain or damage to the skin and 
underlying structures. 
This section now reads: The tester explained to each suiject that the trial at a specific location 
would end if and when the readings Ivent bryond 400 kilopascals. This precautionary measure sen;ed to avoid 
af!J unnecessary pain or damage to the skin and under/ying strue/ures. 
8) Citation of ref.19 was inadequate as it is rat allodynia mode!. 
Reply to comment #8: This reference has been removed from the reference section. 
9) PPT increase (ref 23) was accounted by smoking as a factor. You need to add reference that 
smoking increase PPT thresholds. 
Reply to comment #9: The reference for smoking altering PPT values has been included with 
the foUowing 
Pauli P, Rau H, Zhuang P, Brody S, Birbaumer N: Effects of smoking on thermal pain 
threshold in deprived and minimally-deprived habitual smokers. Psychopharmacology 111:472­
6,1993 
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The two references listed below were recommended by reviewer 1 and have been included in 
the reference section, 
References 
1 Takahashi K, Taguchi T, Itoh K, Okada K, Kawakita K, Mizumura K: Influence of surface 
anesthesia on the pressure pain threshold measured with different-sized probes. Somatosens 
Mot Res 2:299-305: 2005 
2 Itoh K, Okada K, Kawakita K: A proposed experimental model of myofascial trigger points 
in human muscle after slow ecéentric exercise Acupunct Med 22:2-12; 2004 
Major comments and replies: Reviewer # 2 
************************ 
Reviewer 2: comment #1. This paper studies the stability of the PPT determined by an 
electronic algometer when measured over 4 consecutive days. The authors carefully controiled 
for such variables as gender and hormonal variation in the menstrual cycle. The study was weil 
thought out and conducted. The result is unexpected and one that must be considered in short 
term studies, although one that would be expected ta be addressed by a control group in clinical 
studies. Nevertheless, the result is one to be considered by researchers doing studies over 
several days. There is one point that the authors do not address. Figure 6 shows that not ail 
subjects had a decrease in the PPT over 4 days. In sorne subjects, the decrease was quite 
striking. They should address this variability in the response in the results section and in the 
discussion. 
It appears from figure 6 that the drop in PPT in sorne subjects was dramatic. Did that drop 
affect the outcome for the whole group. Were there subpopulations, those with large decreases, 
those with smail decreases, and those with no decrease? If so, was there any identifiable reason 
for the differences? 
Figure 6 is so crowded that it is difficult to follow the course of individual subjects. Perhaps that 
data would be better displayed in a table. 
Reply to Reviewer 2 comment #1. In the results section we have indicated that 3 of the 
subjects did not foilow the trend of decreased PPT values over 4 consecutive days of testing. 
This information has been added on page 9, last paragraph of the results section and now 
reads as foilows: Figure 4 represents aIl PPT values obtained at location 4 (rhomboids) for ail 19 subjects. 
The thick line and points represent the mean ± 5D for each trial and every subject and is in fact the line of 
location 4 presented in Figure 3. The data trend and dispersion shown in Figure 4 is representative of data 
collected at ail 8 locations. Note, however, that there are three subjects (51, 513 and 515) that do notfollow the 
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overal/ trend. In the remaining 16 su!:jects, four su!:jects follow the overal/ trend except on dqy 4 Ivhere the PPT 
values continued to decrease. The individual PPT values are il/ustrated in Fig 4 and are expressed numerical!J as 
means and standard deviations in Table 3. 
We also address this issue of non followers and followers in the discussion. 
We have added a sentence Oast sentence) to the first paragraph on page 13 of the discussion 
section that at reads as follows: This may accountjor some r!f the variabiliry that takes place as shown l:Y 
the nonjol/owers (51, 513, and 5 15) infigure 4. 
Reviewer 2: comment #2. The authors considered the psychological issue of pain perception 
to some extent. Could some of the patients simply have refined their sense of when pain began, 
and become more certain of onset at day 2. The major change appears ta be between day 1 and 
day 2. The authors address this in the discussion, but perhaps they should emphasize that more 
in relationship to other mechanisms such as central sensitizatione, particularly since the PPT 
was more stable between days 2-4. The authors should address the remarkable drop in PPT 
between day 1 and days 2-4 in more detail in the discussion section. In future studies, a break-in 
or training period of testing before a clinical trial rnight address this specific issue, similar to the 
authors' suggestion to discard the day 1 results. 
Reply to Reviewer 2 comment #2. We agree with the reviewer that some subjects may have 
refined their sense of when pain began. We address this issue beginning on page 11 under the 
heading: Factors possibly contributing to the decrease in PPT values. In addition, we 
specifically address central sensitization in the first paragraph on page 13 where we have added 
the following sentences: In fact, Treede et al rifm1l" have investigated brain corticalprocessing r!fpain f:y using 
both PET scan and/MRl imaging and have shown the involvement r!f the thalamus, the primary somatosensory 
cortex (51), the secondary somatosensory cortex (52), the insula,jorebrain and the cingulate cortex (GC). These 
areas have been sUflpted to encode affective motivationalpain aspects (GC and jorebrain), Ivhereas the lateral 
!)stem (51 and 52) is more like!J to accountfor the sensory discriminative pain dimension rift""". 
************************ 
Stylistic concerns: 
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*1) Please add page numbers to your manuscript. 
Reply to comment #1: Done 
* 2) We noticed that there is no "acknowledgment' information that provides sources of 
research support. As stated in the Journal's Instructions for Authors, authors are required to 
disclose sources of research support. This would include grants or departmental funding. You 
should also include any other information as set forth in our Instructions. To recap: "Ali 
authors must disclose any potential conflicts of interest. This includes honoraria, travel to 
conferences, consultancies, stock ownership (excluding publicly-owned mutuaI funds), equity 
interests and patent-licensing arrangements, (particularly if a commercial product is noted in the 
article), and sources of research support. Support staff may also be recogrllzed in this section." 
Reply to comment #2: There was no additional funding or grants to run this project. Ail the 
individuals who participated in the project volunteered their time and energy. The algometer 
was lent to the project by Dr. Karen Messing. 
* 3) Please pay attention to the punctuation used in the references. There is no need ta place 
periods after the initiaIs of the authors' first names, orafter the abbreviated names of the 
journals cited. Journal citations should appear as: Doe J, Jones S, White K: New directions in 
pain management. J Pain 1:10-16,2004 
Reply to comment #3: We have listed ail of the Journal citations as indicated by the above 
example. 
*4) Table 3 does not appear to be cailed out in the text. Please make sure Table 3 is cited. 
Reply to comment #4: Table 3 has been cited. Table 3 has been linked to Figure 4(previously 
figure 6) as the mean and standard deviation values of location 4 over the 4 days of testing. 
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* 5) Some of your references are formatted incorrecdy. For more information on the Journal's 
reference style, scroil to the bottom of this letter. 
Reply ta comment #5: We have gone back over each reference to make sure that they are 
formatted correcdy. 
* 6) Please note that the Journal has recendy instituted a length limit of 600 words for the 
Introduction, and a limit of 1,500 words ta the Discussion. Check those sections to be sure they 
do not exceed the word limits. 
Reply ta comment #6: We have made sure that the word limit in the introduction and the 
discussion has not been exceeded 
Yours truly, 
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Abstract 
The goal of this study was to determine the intra- and inter-day reliability of pressure pain 
thresholds (pPT) in the upper extremity and torso of asymptomatic women. Nineteen healthy 
women (20-39 yrs) with no undedying musculoskeletal problems had three PPT trials 
performed on 8 different locations in the upper extremity and torso over four consecutive 
days. The test-retest reliability of PPT values was robust and highly consistent over the four 
days. The PPT intra-class correlations (ICC) were highly consistent and repeatable over the 
four days of testing (Day 1: ICC = 0.94; Day 2: ICC = 0.96; Day 3: ICC = 0.97 and Day 4: 
ICC = 0.96). When compared to baseline measurements obtained on Day 1, the PPT values 
were significancly lower (p<0.05) on Days 2, 3 and 4 at aU eight locations. Although the PPT 
test-retest reliability is robust and consistent throughout the four days, there appears to be a 
similar overaU decline in the magnitude of the absolute PPT response at each of the eight 
locations. A specifie explanation for this greater overaU sensitivity in PPTs at aU eight 
locations is lacking; however, a centrally-mediated alteration in pressure/pain sensation could 
contribute to the overaU trend observed in this study. 
Perspective: 
PPT measurements of the upper limb and torso will be significancly lower with repeated 
measures over a short period time. a standardized evaluation grid should be included in 
baseline so as to accurately evaluate the progression in shoulder rehabilitation in women with 
shoulder dysfunction. 
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Introduction 
The concept of pressure pain threshold (PPT) and the measurement of the onset of pain 
sensation using the algometer have been the focus and attention of much research and interest 
among clinicians and researchers. Over the last 2S years, the algometer has become widely 
used and accepted in the research literature 11 as weil as the clinical environment 17, as a valid 
tool to evaluate one aspect of pain. The graduaI application of pressure on a section of 
skin/muscle is detected by a force clisplacement transducer within the algometer. The 
progressive development of pressure, by the application of the algometer head, produces a 
graduaI displacement/depression of the local skin surface. The PIT is the point where the 
amount of pressure being applied produces a local sensory shift from pressure to pain. 
According to Nie et al 20, the PIT serves as a useful index for cliscriminating tenderness of 
musculoskeletal structures in problems such as fibromyalgia 17.25, post surgery pain 13 and pain 
related to multiple sclerosis 30. This algometer has been shown to be an effective tool in the 
determination of PIT 26. 28, with a number of the studies focusing on the consistency in 
measures between multiple examiners 1. Thus, it has been hypothesized that PIT values would 
remain constant over time in a healthy population. Unfortunately, there is a paucity of 
information regarding the test-retest reliability of the algometer and the intra-tester reliability 
over time. In fact, two stuclies that did evaluate intra-tester reliability over time came up with 
conflicting results. A study by Nussbaum et al. 21 found reliable and consistent measures over 
time with no difference between the first, second or third day of testing, whereas, a study by 
Sand et al 27 did find a lowering of PIT values over the measurement time periods. Thus, the 
objectives of this study are 1) establish the intra-tester reliability and reproducibility measures 
of PPTs with the use of a hand-held algometer by a single evaluator; and 2) to evaluate the 
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reliability of the algometer in determining the PPT values in women over 4 consecutive days of 
testing. 
Materials and Methods 
Suiject selection: 
Nineteen female subjects 3 with a mean (± SD) age of 23.9 ± 5.2 yrs, mean height of 
1.7 ± 0.1 m, average weight of 64.6 ±10.3 kg and a mean body mass index of 23.6± 3.5 kg/m2 
were recruited from the University and local community. Ali subjects were non-smokers23 
who were involved in sorne form of regular physical activity. The forms of physical activity 
varied and included dance, running, swimming and martial arts. None of the subjects 
experienced any shoulder pain or significant musculoskeletal pain that required medical review 
over the last 6 months. Ail subjects were right hand dominant 22. Subjects were recruited for 
this study following approval of the University Human Research Ethics Committee. Each 
subject was explained the risks of participating in this study and voluntarily gave their written 
informed consent. 
The subjects were asked not to undertake any new physical activity over the four day 
testing period. Subjects were also asked to avoid ingesting any caffeine products for at least 4 
haurs prior ta each testing period. Subjects were asked to avoid any analgesic medication 
throughaut the entire 4-day experimental period. 
The calibration and application of the algometer: 
Calibration: The algometer was calibrated at the onset of each day of testing, before 
being applied to the subject. The algometer (Somedic Sales AB; Model type 2, Sweden) was 
calibrated using a standard protocol that was described and recommended by the 
manufacturer. The protocol required that the algometer be placed on ta a stable surface; we 
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used a table top, with the nozzle surface facing upwards. A one kilogram weight that was 
provided by the manufacturer was applied to the O.Scm diameter applicator head attached to 
the end of the nozzle. Values were obtained and recorded from an LeD display. The 
acceptable calibration values ranged from 98 to 102 kilopascals. \'\!hen the values did not fail 
witmn tms acceptable range (± 2 kilopascals) the algometer was restarted and the calibration 
process was repeated. Identifying marks were placed on the skin, of the upper limb figure 1 
and torso figure 2, so that the tester could repeat the PPT measurements over the same 
locations. 
Application: The O.Scm applicator head (circular disc with a rubberized tip) was 
replaced following calibration with the 2.0cm applicator head to measure PPT's. The 2.0cm 
applicator head (circular disc with a rubberized tip) was used as opposed to the smaller head 
because we were concerned about an increased risk of bruising and localized tissue trauma. In 
addition, there is evidence that the 2.0 cm applicator appears to give indication of local pain 
sensation when compared to smaller applicator heads 31. 
The testing locations were identified through the placement of pen marks on the skin; 
over two (2) anterior locations and six (6) posterior upper torso locations were selected (see 
Figures 1- and 2). The marks served to identify the appropriate location in wmch to place the 
nozzle of the algometer. The experimenter applied the algometer ta each of the eight locations 
in the following sequential manner (i.e., location1 through location 8): 1) the mid-point of the 
muscle fibers of the long head of biceps, 2) the mid-point of the anterior fibers of the deltoid, 
3) the mid-point of the muscle fibers of the lateral head of the triceps, 4) the upper half of the 
fibers of the rhomboids major, S) the mid-point of the posterior fibers of the deltoid, 6) the 
proximal one-tmrd of the fibers of the supraspinatus (the location closest ta the medial border 
of the scapula), 7) the upper fibers of the trapezius (medial to the superior angle of the scapula) 
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and 8) the distal one-third of the muscle fibers of the infraspinatus. The specific locations 
were selected for one of the three following reasons. Several of the locations have been used in 
previous studies such as the trapezius, deltoid and infraspinatus 15,0,34. Other locations have 
often been identified in a clinical setting as being problematic such as the rhomboid and 
supraspinatus 4, 5, 17. Finally, the biceps and triceps were selected because these regions have 
been found to be frequently painful especially in women who have had breast surgery with an 
axillary node dissection for the determination of breast cancer 18. 
The locations on the muscle were chosen based on the possibility of a trigger point 
nodule on the different sites. We recognized that a potential trigger point nodule maybe at the 
locations and we will be presenting that data in a companion paper. We can report that no 
location tested on the 19 subjects had an active trigger point. An active trigger point being 
defined as causing pain and restricting mobility4, 19. Any subject with an active trigger point 
nodule would have been removed from this study. 
Ali subjects were placed in a supine position for the measurement of the bicep and 
anterior deltoid and then moved to the prone position for the measurement of the remaining 
sites. These rwo positions allowed for better stabilization of the arm, shoulder and torso 
compared to the seated position. We elected to follow this sequential order of measurement as 
opposed to randomizing the locations for PPT measurements in order to eliminate repeated 
movements berween the supine to prone positions. Thus, with the subject in the supine 
position, the algometer was applied to the anterior aspect of the shoulder and arm for the PPT 
measurement over the marks located on the anterior deltoid and bicep. With the subject in a 
prone position, the algometer was applied to the posterior aspect of the arm (triceps), shoulder 
(posterior deltoid) and torso (infraspinarus, supraspinarus, rhomboids and the trapezius) for 
the measurement of PPTs. Pillows and padding were used to support the subject's shoulder 
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and arm when appropriate. The total ùme required to coilect three complete sets of data for 
each subject (4 trials total) was approximately 20 minutes. 
Experimental Procedures 
Pilot study: We completed a pilot project in order to test the 8 different locations on 
5 subjects. The goal of the pilot project was to familiarize the evaluator with the algometer and 
to establish the protocol and experimental procedures for tms study. 
Time of testing: The subjects' first day of testing occurred within four days of the last 
day of the subject's menstrual cycle. The subjects were tested over four consecuùve days. Each 
tesùng session took place in the morcùng at approximately the same Ùme of day, over each of 
the four days. 
Order of testing: An icùùal trial was performed at the outset of each tesùng session 
to familiarize the subject to the tesùng procedure. The data from tms trial was discarded. 
Thereafter, three complete sets of data were coilected on the subject. A complete set of data 
included applying the algometer to each locaùon (1 through 8 in sequence) and recording the 
values obtained from the 10caÙon. This order of measurement was done two more ùmes. Each 
trial (of ail 8 locaùons) was recorded on a single data sheet. When the çlata sheet was 
completed, the sheet was removed from view of the tester, so that subsequent data sets were 
coilected without bias. This procedure was repeated for each trial over the four consecuùve 
days. 
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Determination of the pressure pain thresholds (PPTs): At the beginning of each 
testing session, the subject was reminded that the PPT was defined as the "instant or moment 
that the pressure on the skin surface changed from the sensation of pressure to the 
sensation/perception of pain". The tester explained to each subject that they would feel a 
graduaI increase in pressure on the skin. The pressure would continue ta increase until the 
subject experienced a sensory transition from pressure to pain. The tester explained to each 
subject that the trial at a specific location would end if and when the readings went beyond 400 
kilopascals. This precautionary measure served to avoid any unnecessary pain or damage to 
the skin and underlying structures. The tester applied the nozzle of the hand-held algometer at 
each landmark location at an approximate rate of 30 kilopascals per second 5. The increase in 
the force applied to the skin surface was viewed by the experimenter, via the digital output 
display on the algometer. The tester continued ta apply pressure until the subject pressed the 
bunon on hand-held switch indicating that they perceived a sensory transition from pressure 
to pain. The subject never viewed the recorded values. 
5tatistical ana(ysis: 
Descriptive analysis was performed using Microsoft Excel (Microsoft, Redmond, WA) to 
report results as mean ± SD. Significant differences between means were detected by using 
SPSS version 11.5 (SPSS Inc., Chicago IL). A repeated measures analysis of variance was 
performed evaluating the absolute changes in PPT at each location throughout the 4 
consecutive days of testing. A post hoc analysis was performed using a Tukey test. The 
criterion for significance was set at p :s 0.05. 
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Results 
Determination 0/ intra-tester re/iabi/ity (Dqy 1 0/testing) 
The analysis outlined in Table 1 gives an overvlew of the consistency of PPT 
measurements. The intra-tester reliability was highly correlated for the 3 trials performed at the 
8 locations. The intra class correlation coefficient (ICC) for day 1 ranged from 0.92 ta 0.98. 
Determination 0/intra-test dqy re/iabi/ity (Dqys 2, J, and 4 0/testing) 
As weil, as shown in Table 1, the ICC scores were calculated for the 3 trials performed 
at the 8 locations for days 2, 3 and 4. The ICC for days 2, 3, and 4 varied from 0.90 to 0.99. 
PPT intra-class correlations (ICC) were highly consistent and repeatable, 'and 0.93 to 0.98, 
respectively. 
Changes in abso/ute PPT measurements over 4 consecutive dqys 
The data outlined in Table 2 show a significant main effect of time (F277 p<O.OS) 
between days 1 and 4 over ail eight locations. 
Figure 3 shows a significant lowering of PPT values seen on days 2, 3, and 4 across ail 
8 locations when compared to day 1. On day 4, there was a general trend towards an increase 
in PPT values across aIl 8 locations; however they aIl remained significantly lower than day 1. 
Figure 4 represents aIl PPT values obtained at location 4 (rhomboids) for aIl 19 
subjects. The thick line and points represent the mean ± SD for each trial and every subject 
and is in fact the tine of location 4 presented in Figure 3. The data trend and dispersion shown 
in Figure 4 is representative of data collected at aIl 8 locations. Note, however, that there are 
three subjects (Sl, S13 and SlS) that do not foilow the overail trend. In the remaining 16 
subjects, four subjects follow the overail trend except on day 4 where the PPT values 
93 
continued to decrease. The inclividual PPT values are illustrated in Fig 4 and are expressed 
numerically as means and standard deviations in Table 3. 
Discussion 
The main finclings of this study demonstrate that there is a high level of consistency 
among the 3 trials for ail 8 locations; that the PPT measures are reliable over consecutive days 
of testing; and that there is a significant lowering of PPT values observed over consecutive 
days of testing when compared to the day 1 baseline measures. This general trend was 
observed at each of the eight locations inclicating that the subjects experienced a greater 
sensitivity in PPT in the upper arm and torso over time. In fact, the greatest decline in PPT 
values took place between day 1 and day 2, afterwards the rate of decline in PPT values 
climirushed (between days 2 and 3)and by day 4 the PPT values started to increase but still 
remained significantly lower than the day 1 values. 
Although reductions in PPT over time have been observed in subjects experiencing 
migraine/chroruc headaches 5.2\ to the best of our knowledge there are no other stuclies that 
showed a similar trend in a non-clirucal population. In fact, our cohort was obtained from a 
normal healthy subject population and we hypothesized that the PPT values would be either 
consistent 21 or demonstrate an increase over time o. 
A study by Nussbaum et ae1 showed no clifference in PPT values over consecutive 
days of testing. There are several differences between the Nussbaum study and the present 
study that could possibly explain the differential finclings. For example, N ussbaum et al (1997) 
used both males and female subjects, did not consider a women's menstrual cycle 2 in the 
testing protocol, tested one location the biceps brachü and used a manual algometer with 
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verbal feedback tested. We had only female subjects, coincided the first day of testing with the 
subject's menstrual cycle, tested 8 different locations and used an e1ectronic algometer. 
Electronic algometers have been shown ta be more sensitive in defining PPT values compare 
to manual algometers, with electronic algometers indicating significancly lower PPT values 
when compared ta manual algometers at the same location 9. 
We show that over 4 consecutive days of testing there is a decrease in PPT values. In 
contrast, a study by Persson et al 0 having a similar design of repeated measures but not on 
consecutive days (day 1, 3, 28 and 30) showed a significant increase in PPT values. The major 
clifferences between our study and Persson's study involve the subjects used in the project and 
the testing periods. The subjects in our study were in a more defined age range (20-39 years) 
compared to Persson et al 0 where 24 women (24-59 years) were evaluated on 4 separate days 
(1, 3, 28, 30). Ali of the women in our study had regular menstrual cycles and were non 
smokers, while in the Persson 0 study, several women (n= 6) were menopausal and sorne of 
the women were smokers. In fact, a study has shown that smoking influences PPT 
measurements 23. We tested 8 locations on the right side of the upper arm and torso, while 
Persson et al bilateraily tested 3 locations on the trapezius and 4 locations on the deltaid for a 
total of 14 locations. Thus, ail of these combined factors may account for the differences 
observed between our study and Persson et al's. 
Factors possibjy contributing to the decrease in PPT values 
The decline in PPTs over the 4 days of testing may be due to one or more of the 
foilowing factors: 1) A learned behaviour whereby the subject anticipates the PPT and 
depresses the button; 2) Tissue trauma or bruising of the location creating a more sensitive 
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area; and 3) A more complex central mecharusm that elicits an earlier activation of the 
superficial and deep nociceptors. 
It is possible that sorne form of learned behavioral response or anticipatory eue 
influenced or guided the subjects to respond sooner to the pressure of the algometer head on 
days 2, 3, and 4 when compared to baseline (dayl). It is conceivable that the subjects began to 
anticipate when the PIT was approaching. This may have allowed the subject to be more 
aware of when the PIT leve1 had been reached. This learrung response clid not occur on any 
one day; if it had then the Iee values would have been affected. A significant difference would 
have been seen between trials at the same location on the same day. This is in contrast to 
Persson et al 0 where a graduaI increase in PIT values was noted in between trials on the same 
day. 
The raw PPT scores on each day show little variation berween trials at each location. 
But there was sigrùficant clifference in PIT values obtained on day 1 and the PIT values 
obtained on the subsequent days of tesring for each location. If a learrung effect actually 
occurred, then it took place in between each day of testing and included the whole testing 
period, it is less like1y to have taken place between each trial on any specifie day of testing. 
A second probable factor that may have accounted for the lowering of PIT values 
over rime is the increase in sensitization of localized nerve receptors and local tissue trauma 
possibly brought on by the repeated pressure of the algometer head. If there was trauma 
around the affected area, it probably involved more superficial pain receptors embedded in the 
skin. Tt is possible that a small trauma occurred at each of the 8 location and thereby lowering 
the PIT value at each site. In a few instances, a faint cliscoloration at the selected testing 
locations was observed on the skin over the bicep brachii in five subjects. Discoloration is 
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often associated with tissue trauma or the onset of a hematoma 7. A second factor associated 
with tissue trauma is an increase in the subject's sensitivity. It is foreseeable that some of the 
subjects may have experienced a change in sensitivity over some of the locations. Work by 
Treede et al 33 has shown that cutaneous analgesia does not have a significant influence on 
PPT values, thus a change in sensitivity is an unlikely outcome to explain the decrease in PPT 
values that we have observed. 
A third possibility in the lowering of the PPT values may involve some form of central 
response which may have included components of both the learning on the part of the subject 
and very mild tissue trauma. The central and peripheral nervous systems are thought to have 
certain plasticity when it comes to learning 7,1\ being able to adapt and change rather quickly. 
A good example of this is in the area of pain, where free nerve endings, (nociceptive neurons) 
have been shown to not only respond to a single stimulus but have been shown to increase 
their readiness to fire during repeated stimulation 16. This repeated noxious stimulation has 
been shown to cause central nervous system changes 14. In fact, Treede et al32 have investigated 
brain cortical processing of pain by using both PET scan and fMRI imaging and have shown 
the involvement of the thalamus, the primary somatosensory cortex (Sl), the secondary 
somatosensory cortex (S2) , the insula, forebrain and the cingulate cortex (GC). These areas 
have been suggested to encode affective motivational pain aspects (Ge and forebrain), 
whereas the lateral system (Sl and S2) is more likely to account for the sensory discrirninative 
pain dimension32. It is clear that in our study a painful response was being provoked repeated1y 
not only on one day, but over 4 consecutive days. It is unclear whether there was sufficient 
stimulation to cause some form of physiological adaptation. Nonetheless, this may account for 
some of the variability that takes place as shown by the non-followers (Sl, SB, and S 15) in 
figure 4. 
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A possibility of a central response being elicited at ail 8 locations may have been 
related to the presence of trigger points. Trigger points are known to be hypersensitive 
locations in the muscle and have been implicated in causing referred pain 19. Referred pain is 
thought to have a central mechanism 8 which is believed to be bidirectional and modality 
specifie to either a single or repeated response. 
Limitations: 
One of major limitation with our study is the lack of information on the physiological 
responses (i.e. change in cytokine levels) that may have taken place in the tissue at each of the 
testing sites. Another limitation was the failure to ask subjects if they perceived a lowering in 
their PPT value. Did the subjects notice that the location was becoming more sensitive or that 
they were aware of when the PPT value had been adùeved at each site? 
Conclusion: 
In conclusion, we have shown a decrease in PPT values over 4 consecutive days, 
especiaily between Day 1 and Day 2 of testing. The nature of the decrease in PPT values is 
unknown but may involve local micro trauma over the measurement site or a central response. 
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Table 1: Consistency of repeated trials over the 4 days of testing- Reliability 
Intra class Correlation Coefficients (Consistency Definition) 
Day 1 Day 2 Day 3 Day 4 
Location rcc rcc rcc rcc 
Location 1 0.96 0.97 0.97 0.96 
Location 2 0.98 0.98 0.96 0.98 
Location 3 0.96 0.97 0.99 0.98 
Location 4 0.92 0.97 0.97 0.96 
\ 
Location 5 0.94 0.95 0.97 0.98 
Location 6 0.93 0.90 0.96 0.93 
Location 7 0.92 0.97 0.97 0.96 
Location 8 0.93 0.94 0.97 0.94 
Confidence Interval ICC- 95%, nc= Intra Item correl~tion of the 3 trials 
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Table 2 Average means and standard deviations across 4 days of testing 
Day 1 Day 2 Day 3 Day 4 F & P values 
(Baseline) 
Location X SO X SO X SO X SD F P 
Location 1 150.09 ± 77.15 123.37 ± 79.44 * 123.61 ± 81.50 *€ 136.83 ± 81.60 *[ 7.22 < 0.05 
Location 2 160.28 ± 72.39 138.00 ± 73.91 * 131.24 ± 76.81 * 145.00 ± 77.29 *[ 7.65 < 0.05 
Location 3 174.95 ± 73.40 146.46 ± 77 .94 * 139.37 ± 80.42 * 146.33 ± 81.40 *[ 11.13 < 0.05 
Location 4 246.53 ± 78.01 219.77 ± 75.97 * 208.27 ± 76.30 * 220.57 ± 78.51 *[ 6.64 < 0.05 
Location 5 232.1 9 ± 77.77 191.21 ±74.11 * 187.18 ± 73.55 * 201.67 ± 76.06 *1 11.94 < 0.05 
Location 6 228.79 ± 80.90 195.18 ± 75.18 * 180.78 ± 82.75 *f 190.57 ± 80.92 * 12.54 < 0.05 
Location 7 244.70 ± 78.34 213.56 ± 76.01 * 207.16 ± 79.93 * 210.36 ± 78.34 * 7.30 < 0.05 
Location 8 211.18 ± 76.48 180.70 ± 72.34 * 171.57 ± 78.85 * 181.93±72.16* 8.69 < 0.05 
Abbreviation F =2.77, p~ 0.05 
* Significant difference between day 1 and day 2, day 3 and day 4(P<0.35 to P<O.OO) 
€ The variance for day 2 = 6310.95, the variance for day 4 = 6658.58 leading to a P = 
0.07,indicating no significant difference between the 2 days, the variance for day 3 =6642.36 
and day 4 = 6658.58 leading to a P = 0.02 indicating a significant difference between the 2 days 
f Significant difference between day 2 and day 3 (P=0.02) 
[Significant difference between day 3 and. day 4(P<0.05 to P<0.01) 
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Table 3: Mean PPT values of repeated daily trials over 4 days of testing at location 4 
Trial 1 Trial 2 Trial 3 
Day 1 252.95 ± 74.34 244.84 ± 87.06 241.79 ± 73.58 
Day 2 218.37 ± 79.97 223.05 ± 72.29 217.89 ± 78.84 
Day 3 211.47 ± 81.46 203.71 ± 76.98 209.65 ± 73.26 
Day 4 214.64 ± 80.65 227.00 ± 80.03 220.07 ± 78.25 
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Figure legend 
Figure 1. Location of marks (X) on the anterior surface of the upper arm and shoulder. 
An indelible ink mark was placed on the anterior fibers of the deltoid muscle 
and on to the long head of the biceps brachü muscle. The hand-held algometer 
is being applied to a location on the upper arm on the anterior surface of the 
subject, with the subject lying in a supine position 
Figure 2. Location of marks (X) on the posterior surface. An indelible ink mark was 
placed on the posterior fibers of the deltoid muscle (not shown), lateral head of 
the triceps brachi muscle (not shown), supraspinatus muscle, rhomboids 
muscle, trapezius muscle and the infraspinatus muscle. The hand-held 
algometer is being applied to a location on the torso of the posterior surface of 
the subject, with the subject lying in a prone position. 
Figure 3. Time course of PPT changes over 4 days of consecutive measurements over 8 
locations. The data presented for each location are mean values. SDs have been 
omitted for sake of clarity. SDs are provided in Table 2. The text in the 
parentheses inclicates the location number. 
Figure 4. Time course of location 4 (rhomboid) PPT changes for ail 19 subjects over 4 
days of consecutive measurements for each three trials per day. The thick grey 
line in the background represents the group average ± SD. The figure in the 
inset represents the time course for location 4, which is taken from Figure 3. 
The text in the figure legend represents the corresponcling subject number. 
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CHAPTERIV 
MANUSCRIPT NUMBER 2 
4.01 Overview of the second manuscript 
This manuscript deals the original hypothesis conceming variation in the pressure pain 
threshold at the eight different locations. This manuscript was also presented as part of the 
research poster presentations at the annual Canadian Athletic Therapy association 
conference in Winnipeg in May, 2007. 
Again the correspondence is between the joumal's editor and Dr. Alain Comtois 
supervisor of the M.Sc candidate. AlI work has been done by Mr. David H. Jones both 
Dr. Comtois and Dr. Ki1gour have made significant comments on the manuscript. 
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4.02 Letter of acceptance for poster presentation competition from the 
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112 
4.03 Submitted manuscript 2 
Regional variation in pressure pain threshold measurements 
of the upper arm and torso in young healthy women 
David H. Jones, M..Sc., CAT (C), CSCS, 1.2 Robert D. K..ilgour Ph.D., FACSM, 1 
Alain S. Comtois Ph.D., FACSM,2 
1Department of Exercise Science 2Département de Kinanthropologie 
The Richard J. Renaud Science Complex Université du Québec à Montréal 
Concordia University CP 8888 Succursale, centre-ville 
7141 Sherbrooke Street West Montreal, QC
 
Montreal, QC H3C 3P8
 
H4B 1R6
 
Address for reprints: 
David H. Jones, M.Sc., CAT (C), CSCS,
 
Departrnent of Exercise Science
 
The Richard J. Renaud Science Complex
 
Concordia University
 
7141 Sherbrooke Street West
 
Montreal, QC, H4B 1R6 
113 
Tel: 514-848-2424 ext 3318
 
Fax: 514-848-8681
 
E-mail: dhjones@alcor.concorclia.ca
 
114 
Abstract: 
The purpose of this study was to evaluate the variation in pressure pain threshold 
(PPT) values in eight different locations of the upper arm and torse over four 
consecutive days of testing. Nineteen coilege-aged women (20-39 yrs) with no 
underlying musculoskeletal problems participated in the study. Over the testing 
period, the upper arm and anterior shoulder regions were found to have significantly 
lower PPT values (P< 0.05) when compared to PPT values on the posterior shoulder 
and torso. Four locations on the torso had PPT values that were consistently higher 
than the grand PPT mean of ail eight locations. Of ail the locations measured, the 
PPT on the infraspinatus muscle was found to be consistently around the grand 
mean over the four days of testing. 
Perspective: 
PPT measurements performed on the upper arm and anterior shoulder have been 
shown to be significantly lower compared to the posterior shoulder and torse in 
normal healthy women. These differences should be recognized and included in 
baseline values so as to accurately evaluate the progress in women, especiaily those 
with shoulder dysfunction. 
115 
Introduction 
Over the last four decades, researchers have taken a significant interest in determining 
the incidence of musculoskeletal pain that develops in the neck, shoulder and arm regions of 
people working at various jobs requiring repetitive movements for extended periods of rime 
3,8,11. Those considered to be at risk for developing pain in the neck, shoulder and arm regions 
. Id" 30 d l h . . 24 2S hi 11 d l h kmc u e mUSlClans, enta yglerusts', cas ers an peop e w 0 wor at computer 
terminals19• In the majority of these positions, the high incidence of pain is associated with 
tasks that have low biomechanical demands that are performed for extended periods of 
time27 . A second observation is the significantly greater percentage of women than men who 
are affected by this problem4,8. These individuals not oruy endure pain and dysfunction but 
also a diminished quality of life17• 
Many protocols and measurement devices have been used to assess the efficiency of 
different therapeutic interventions of the upper arm and torso12,17. Among the measurement 
dêvices used is the algometer. The algometer is a valid and reliable tool that is commoruy 
used to assess the subject's pressure pain threshold (PPT) 18,21. 
The algometer has been used to gain an understanding of muscle tissue sensitivity on 
single 29 and multiple site locations6 in the upper and lower regions of the body. These and 
other different models have been tested 21,22 but none to our knowledge has been designed to 
assess and evaluate specific regions that may eventually be implemented in a clinical setting. 
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A recent srudy from our laboratory Gones et al. 2007) established the test-re-test reliability of 
a protocol that evaluated PIT sensitivity in a group of healthy asymptomatic young women. 
In establishing the test-re-test reliability in the eight sites over the four days, we cliscovered an 
interesting trend in PIT values accorcling to the regions and locations tested. In this paper, 
we reported the regional clifferences in PIT and the significance that these presented in a 
normal population of women.. We observed that not alilocations had the same PIT values 
and that some locations are more sensitive than others as evidenced by the consistent 
clifferences at specifie locations on the upper body and torso. 
Materials and Methods 
Subject selection: 
Nineteen female subjects with a mean (± SD) age of 23.9 ± 5.2 yrs, height (1.7 ± 0.1 
m), weight (64.6 ±10.3 kg) and body mass index (23.6± 3.5 kg/m2) were recruited from the 
University and local community following approval of the University Human Research 
Ethics Committee. Each subject was explained the risks of participating in this srudy and 
voluntarily gave their written informed consent. AlI subjects were non-smokers20 who were 
involved in some form of regular physical activity including dance, running, swimming and 
martial arts. None of the subjects experienced any shoulder pain or significant 
musculoskeletal pain that required meclical attention over the last 6 months. AlI subjects were 
right hand dominant18• 
The subjects were asked not to undertake any new physical activity over the testing 
period of four consecutive days. Subjects were also asked to avoid ingesting any caffeine 
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products for at least 4 hours prior ta each testing period. Subjects were asked to avoid taking 
any ana!gesic meclication throughout the encire 4-day experimental period. 
Test locations 
The algometer (Somedic Sales AB; Model type 2, Sweden) calibration and 
application in this study are discussed in detail in] ones et al (2007). 
The testing locations were identified through anatomical reference landmarks on the 
skin surface. The placement of pen marks on the skin over two (2) anterior locations and six 
(6) posterior upper torso locations served to identify the anatomicallandmarks and location 
of where the nozzle head of the algometer was placed (see Figure 1). The experimenter 
applied the algometer ta each of the eight locations in the following sequential manner (i.e., 
location1 through location 8): 1) the mid-point of the muscle fibers of the long head biceps 
(Bb), 2) the mid-point of the anterior fibers of the deltoid (AD), 3) the mid-point of the 
muscle fibers of the lateral head of the triceps (Tri), 4) the upper half of the fibers of the 
rhomboids major (Rht\1), 5) the mid-point of the posterior fibers of the deltoid (PD), 6) the 
proximal one-third of the fibers of the supraspinatus (Sup) (the location closest to the meclia! 
border of the scapula), 7) the upper fibers of the trapezius (Trap) (meclial ta the superior 
angle of the scapula) and 8) the clistal one-third of the muscle fibers of the infraspinatus (lnf). 
The specific locations were selected for one of the three following reasons. Severa! of the 
locations have been used in previous stuclies such as the trapezius, deltoid and infraspinatus 
Il,28. Other locations such as the rhomboid and supraspinatus 5,6,14 have often been identified 
in a clinical setting as being problematic.. Finally, the biceps and triceps were selected because 
these regions have been found to be frequently painfui especially in women who have had 
breast surgery with an axillary node clissection for the determination of breast cancer 13. 
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The specifie locations on the muscle were ehosen based on the probability of the 
existence of a trigger point nodule on the different sites (refs). We recognized that a potential 
trigger point nodule may be at these locations and we will be presenting those data in a 
follow-up companion paper. We can report that none of the 19 subjeets tested had an active 
trigger point. An aetive trigger point being defined as causing pain at rest and restricting 
mobility4. 14. Any subjeet with an active trigger point nodule wouId have been released from 
this study. 
Ail subjects were placed in a supine position for the PVf measurement of the bicep 
and anterior deltoid and then moved to the prone position for the measurement of the 
remaining sites. These two positions allowed for better stabilization of the arm, shoulder and 
torso compared to the seated position. We elected to follow this sequential order of 
measurement as opposed to randomizing the locations for PPT measurements in order to 
elirninate repeated and numerous movements of the subjects between the supine to prone 
positions. Thus, with the subject in the supine position, the algometer was applied to the 
anterior aspect of the shoulder and arm for the PVf measurement over the marks loeated on 
the anterior deltoid and bicep brachii. With the subject in a prone position, the algometer 
was applied to the posterior aspect of the arm (triceps), shoulder (posterior deltoid) and torso 
(infraspinatus, supraspinatus, rhomboids and the trapezius). Pillows and padding were used 
to support the subject's shoulder and arm when appropriate. The total time required to 
collect three complete sets of data for each subject was approximately 20 minutes. 
Although randomizing the order of application would have made for a stronger 
research design, we decided for reasons of logistics and optimum experimental control to 
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specify the order of application. It is expected that this template will be used on groups of 
women who have neck, shoulder and upper arm problems. Tt was decided that testing ail of 
the anterior locations should be done first and then the subject would tum over to a prone 
position for ail the posterior location measurements. With 4 trials of measurements at each 
location the subjects were required to tum from supine to prone or prone to supine 8 
different times during the testing period. Randomization would have made the 
measurements extremely tedious for the subjects. 
Experimental Procedures 
Time of testing: The subjects' first day of testing occurred within four days of the 
last day of the subject's menstrual cycle!. The subjects were tested over four consecutive days 
and each testing session took place at approximately the same time each morning. 
Order of testing: An initial trial was performed at the outset of each testing session 
to familiarize the subject to the testing procedure. The data from this trial was discarded. 
Thereafter, three complete sets of data were coilected on the subject at each location (1 
through 8 in sequence). Each trial (of ail 8 locations) was recorded on a single data sheet. 
When the data sheet was completed, the sheet was removed from view of the tester, so that 
subsequent data sets were collected without bias. This procedure was repeated for each trial 
over the four consecutive days. 
Deteroùnation of the pressure pain thresholds (pPTs): At the beginning of 
each testing session, the subject was reminded to press the button on the hand-held switch 
the "instant or moment that the pressure on the skin surface changed from the sensation of 
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pressure ta the sensation/perception of pain". Each subject was informed that they would 
feel a graduaI increase in pressure on the skin when the nozzle of the algometer was applied. 
The pressure would continue to increase until the subject experienced a sensory transition 
from pressure to pain. Each subject was told that the trial would end if and when the 
algometer reading went beyond 400 kilopascals. ms precautionary measure served to avoid 
any unnecessary pain or damage to the skin and underlying structures. The experimenter 
appliedthe nozzle of the hand-held algometer at each landmark location at an approximate 
rate of 30 kilopascals per second6. The increase in the force applied to the skin surface was 
viewed by the experimenter via the digital output display on the algometer. The experimenter 
continued to apply pressure until the subject pressed the button on hand-held switch 
indicating that they perceived a sensory transition from pressure to pain. The subjects never 
viewed nor were they informed of the recorded values. 
Statistical anafysis: 
Descriptive analysis was performed using J\1icrosoft Excel (Microsoft, Redmond, 
WA). Ali values are reported as mean ± S.D. Significant differences between means were 
detected using SPSS version 11.5 (SPSS lnc., Chicago IL). A repeated measures ANOVA 
was performed evaluating the mean changes in PPT at each location throughout the 4 
consecutive days of testing. A post-hoc analysis was performed using a Tukey test. The 
criterion for significance was pre-set at p :S 0.05. 
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Results 
The main effect of an analysis of variance indicated that there was a significant 
difference in PPT values obtained at the 8 different locations over the 4 days of testing. Post 
hoc analysis showed that location 1, 2 and 3 had significancly lower PPT values compared to 
ail other locations over ail 4 days of testing (Table 1). The critical F= 2.08, over the 4 days of 
testing with; F=38.83 on day 1; F= 39.90 on day 2; F= 26.18 on day 3 and F= 15.76, P < 
0.05 on ail 4 days. 
What foilows is a detailed breakdown of the post hoc analysis at each location (Table 1). 
Differences per location over the 4 days of testing 
Locations 1 biceps brachii, 2 anterior deltoid and 3 triceps brachii 
The PPT values obtained at these 3 locations were significancly lower than the PPT 
values obtained at the other 5 locations (p<0.00) over ail 4 days of testing. There was a 
significant difference between location 1 (Bb) and location 2 (AD) (p=0.02) and 3 (Tri) 
(P=Ü.ÜO) on day 1 of testing. There was no difference between the 3 locations on days 2, 3 
and 4 of testing. 
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Locations 4 rhomboids major, 5 posterior deltoid and 7 trapezius. 
The PPT values obtain at locations 4 (Rhl'v1), 5 (PD) and 7 (frap) were significantly 
greater ( p<O.OO) than the PPT values obtained at the other 4 locations; 1 (Bb), 2 (AD), 3 
(fri) and 8(Tnt), over the 4 days of testing. 
Location 6 the supraspinatus 
The ppt values for location 6 (Sup), were significantly greater than the PPT values of 
locations 1, 2, 3, (p<0.00) over the 4 days of testing. Over the 4 days of testing location 6 
(Sup) showed the same variation in ppt values as locations 4 (RhM), 5 (PD) and 7 (frap). 
On day 1 the ppt values for location 6 (Sup) were significantly different From location 8 (Tnt) 
(p=0.04). On day 2 ppt values for location 6 (Sup) were significantly From location 4 (RhM) 
(p<0.00). On day 3 the PPT values of location 6 supraspinatus, were significantly different to 
the PPT values From 5 of the 7 locations, the exceptions being location 5 (PD) (p=0.34) and 
8 (Tnt) p=0.11). On day 4 the PPT values of location 6 (Sup), were significantly different to 
the PPT values From 6 of the 7 locations, the exception being location 8 (Tnt) (p=0.14). 
Location 8 the infraspinatus 
The PPT values for location 8 (Tnt) were significantly different From PPT values 
recorded at ail other locations on day 1. The difference between location 8 (Tnt) and location 
6 (Sup) was (p=0.Ü4). The significant difference in PPT values, continued over ail 4 days, 
across 6 of the 7 locations. At location 6 (Sup), there was no difference in PPT values on 
days 2(p=0.08), 3(p=0.11) and 4(p 0.14) when compared ta location 8. 
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The following section is a comparison of the mean PPT values for each location to 
the Grand Mean of PPT values of ail locations. Figures 2 a-2d, 3 
Comparing mean PPT values to grand mean of PPT values 
A comparison was performed, looking at the mean PPT values of one location and 
comparing it to the grand mean of the PPT values of ail 8 eight locations, figure 2( Day 1). 
Alliocation points were normalized to the overall mean value of the 8 location points. \'V'hen 
examining Figure 2, three distinct trends are seen in the data collected over 4 days of testing. 
First, the PPT values of locations 1 (Bb), 2 (AD), 3 (Tri) were consistently below the mean 
(15%-29%) for all 3 trials. Secondly, the PPT values of locations 4 (RbM), 5 (PD), 6 (Sup) 
and 7 (Trap) were consistently above the mean (7%-29%) for ail 3 trials. Thirdly, the PPT 
values at location 8 infraspinatus were consistently around the mean (1.00%- 1.04%) for ail 3 
trials. This can be seen in Figure 3. The variation in PPT values obtain for a location on each 
day remained significantly different over ail four days of testing. Figures 2a-2d shows the 
variation between trials on each day. 
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Discussion: 
The main findings of this study demonsttate a significant regional difference in the 
PPT values of the arm and upper torso. The PPTs of the arm and anterior shoulder (e.g., 
biceps, anterior deltoid and triceps) were sirnilar to one another but were significantly lower 
than those measured in the torso (e.g., rhomboids, posterior deltoid, supraspinatus, trapezius, 
and infraspinatus). This indicates selective regional pressure/pain sensitivity in a group of 
asymptomatic women. The PPT values feil into one of three significantly different groups. 
In the first group the PPT values were lower than the grand mean; in the second group the 
PPT values were higher thart the grand mean and in a third group the PPT values were close 
to the grand mean. The grand mean was the mean value of ail eight locations across ail 19 
subjects. 
When using an algometer as a diagnostic tool, the clinician/researcher should expect 
lower PPT values in the upper arm compared to the torso with the understanding that a 
lower PPT value does not necessarily indicate an underlying problem. Ir is possible that these 
3 locations with the lower PPT values may have a greater density of free nerve ending 
compared to the other 5 locations, making them more sensitive ta the perception of pressure 
pain. If the upper arm does become problematic, the clinician working with a patient to 
resolve this problem, should not expect PPT values in the upper arm to attain the same PPT 
levels in the torso, as the area is being rehabilitated26• 
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The PPT values for the rhomboids major and the trapezius were approximately 20% 
greater than the mean. Both muscles have been frequently associated with neck and back 
pain and dysfunction in the upper extrernity 8especially the trapezius. It is possible that the 
locations with high pain thresholds only become problematic after sorne form of tissue 
damage has occurred, which may make them more difficult treat. If either of these locations 
were to become problematic, it is possible that the PPT values obtained at the rhomboids 
major and the trapezius may be at the same level or even slightly higher, than other test 
locations. This may give the false impression that the locations are not problematic, when in 
reality there is sorne form of dysfunction present26• The clinician/researcher must take this 
into consideration when analysing PPT values. 
Location 8 infraspinatus had PPT values that were close ta the grand mean, over all4 
days of testing. Location 6 supraspinatus did have PPT values that were sirnilar ta location 8 
infraspinatus but had much more variation over the testing period. Using the infraspinatus 
(and possibly supraspinatus) as reference points, clinicians and researchers may be able to 
estimate the PPT values of the other 6 locations26. This approach may be appropriate as long 
as the infraspinatus itself does not become problematic and the same locations are used to 
evaluate PPT levels. This value would probably vary if more or less locations were to be used 
or if different locations were to be used. 
In a previous studl, we indicated that there was a significant decrease in PPT values 
over 4 consecutive days of testing. This decrease in PPT values over time did not affect the 
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differences between the testing locations. The same locations remained more sensitive or 
less sensitive over ail four days of testing. The variation over time as weil as detailed analysis 
of the ICC scores was described previously9 
Whyare there 3 distinct groupings ofPPT values? 
The subjects may have been influenced by seeing the application of the algometer 
being applied to their arm. Lying in a supine position, and the head in a neutral position the 
subjects may have been able ta view the algometer being applied ta their arm, even though 
the subject did not see the digital display, they may have been influenced by the site of the 
algometer being pushed down upon their upper arm and shoulder. This remains plausible 
except that the durd location which had low PPT values was on the triceps. \l<ffien testing 
the triceps, the subject was lying in a prone position and had limited view of the algometer 
when it was applied to this location. Future studies should look to blind folding subjects to 
diminish visual input as a confounding variable. 
Another possible explanation for the differences in recorded PPT values maybe due 
to the difference in nervous innervation and the vascular supply of the locations being tested. 
Seven of the eight locations had a different nerve supply16; the only location that had the 
same nervous input was anterior and posterior deltoid. A comparison between location 2, the 
anterior deltoid and location 5, the posterior deltoid, show a significant difference in PPT 
values between the 2 locations. \l<ffiere the anterior portion of the deltoid was significandy 
more sensitive and had lower PPT values than the posterior portion, even though both are 
127 
innervated by the same nerve (axillary) 16. The brachial plexus is the nervous supply that 
innervates the arm and is positioned more superficial on the anterior surface of the upper 
body compared ta the posterior surface 16. With the brachial plexus being in close proxirnity 
to the anterior deltoid it may have lead to an increase in sensitivity which may account for the 
difference in PPT values 16. 
In this srudy the locations being tested were the rnid point of the anterior fiber and 
the rnid point of the posterior fibers. In a srudy by Baker et a1.2 different areas of a muscle 
(recrus femoris) were found to have different values. The proximal and distal tendon bone 
junctions were shown to have increased sensitivity and lower PPT values when compared to 
the rnid point of the muscle. In this study the rnid point of the anterior fiber of the deltoid 
and the rnid point of the posterior fibers were tested and fond to be significancly different. 
A third reason why we observed differences in PPT values at the 8 locations maybe 
due the location of the muscles. Posterior muscles maybe less sensitive than anterior muscles, 
with the upper back being considered less sensitive than other areas that were tested. In one 
srudy 6the back and torse region was found to have higher PPT values when compared to 
other locations6• This is consistent with our results and maybe related to free nerve ending 
. 16denslty . 
A fourth and possible final reason for the differences in the 8 locations, maybe 
related to the order in which the PPT values were assessed. As outlined in the methods 
section we did not randornize the order in which the locations were tested. We wanted to 
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avoid excessive movement of the subject, which may have compromised stabilization of the 
subject's torso or shoulder. This may have influenced the values obtained. If the order of 
application was a factor then a follow up study randomizing the locations wouId be 
appropriate. Moreover, if the order of application was a significant factor then we should 
have seen a graduaI increase or decrease in PPT values based on the order the algometer was 
being applied to the testing locations. This wouId have meant that location 1 should have had 
either the lowest or the highest PPT value and location 8 should have had the corresponding 
inverse, with the highest or lowest PPT values. This did not take place. Looking at table 1 we 
see a progressive increase in PPT values at the first 4 locations, followed by a drop at location 
S,PD, a drop in location 6,Sup, an increase in location 7 , Trap and a final drop in location 
8,Inf. 
Application: 
In the work force individuals whom are at risk of developing repetitive movement 
syndrome have become very interested in finding solutions to overuse problems for these 
individuals. The financial cost from lost man hours and the increased work required to hire 
competent replacement workers IShas had a negative impact on a company's bottom line. To 
determine if an individual is ready to return to work, individuaIs and companies have looked 
to the medical community for guidance, with the return to work being based on the 
attending physician's recommendations23. Studies have shown that the physician/surgeon's 
recommendations for return to work after surgery maybe highly variable23, with 
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recommendations being based less on objective measures and more on the perceived patient 
readiness to retlun to work 23. Physicians, through the help of ergonomists (whom are the 
eyes in the work place setting) maybe able to combine the template with additional objective 
tools to determine when it is appropriate for someone to safely return to work without 
aggravating problems in the neck, upper torso and arm. 
A patient experiencing pain in the trapezius location was able tolerate x amount 
pressure at the initial evaluation. The values on the trapezius were dose to the values 
obtained while testing locations on the upper arm. After a number of weeks of rehabilitation 
the patient is now able to y amount of pressure, which is significantly greater than the values 
on the upper arm and is doser to the ratio values we would anticipate for the individual, 
approximately 15-20 % greater than the grand mean of the 8 locations. 
Limitations: 
The template for this study was used on healthy individuals who did not have any 
musculoskeletal problems at present. Moving the template to a group that has underlying 
problems in the neck, upper back, shoulder, arm and region may lead to different findings. 
Individuals with chronic and acute pain are shown to have very different responses7•8• 
Individuals with chronic palO associated with repetitive movement syndromes have both 
physiological and psychological adaptations, which are not accounted for with this model. 
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Future Projects: 
Moving the template to a population that is at risk of developing upper arm torso 
problems is the next logical step. This would entail doing a pre-test evaluation on specific 
groups such as females who perform repetitive tasks for sustained periods of time or women 
who are undergoing some type of medical intervention that has been known to adversely 
affect the shoulder, such as adjuvant therapy associated with breast cancer. Then following 
up with the group 4-6 months later to see if anything has changed at the testing sites or 
whether different therapeutic interventions have improved the situation and made the 
locations less sensitive. 
Conclusion: 
There was a significant difference between the 8 different locations that were 
evaluated over the 4 days of testing. Locations on the arm and anterior shoulder were more 
sensitive and had lower PPT values than locations on the upper torso and posterior shoulder. 
The PPT values of one location, on the infraspinatus, were consistenrly around the grand 
mean of ail 8 locations. Before the infraspinatus could be considered representative of the 8 
locations, many more tests need to be performed. 
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List of Figures 
Figure la: A photograph identifying the ink marks on surface of the skin over the anterior 
fibers of the deltoid muscle, long head of the biceps brachü muscle. 
Figure 1b: A photograph identifying the ink marks on surface of the skin over the posterior 
fibers of the deltoid muscle, lateral head of the triceps brachü muscle, supraspinatus muscle, 
rhomboids muscle, trapezius muscle and the infraspinatus muscle. 
Figure 2a: Day 1 Repeated measures of Pressure pain threshold values at 8 locations. The 
figure shows that 3 trials were repeated at each location. The standard deviation is shown for 
each trial. 
Figure 2b: Day 2 Repeated measures of Pressure pain threshold values at 8 locations. The 
figure shows that 3 trials were repeated at each location. The standard deviation is shown for 
each trial. 
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Figure 2c: Day 3 Repeated measures of Pressure pain threshold values at 8 locations. The 
figure shows that 3 trials were repeated at each location. The standard deviation is shown for 
each trial. 
Figure 2d: Day 4 Repeated measures of Pressure pain threshold values at 8 locations. The 
figure shows that 3 trials were repeated at each location. The standard deviation is shown for 
each trial. 
Figure 3: The ratio between the 8 locations and the Grand Mean (1) over 4 days of testing. 
The mean PPT values expressed as a ratio of 3 trials obtained for each location over 4 
consecutive days of testing. Values above and below "1" identifies the ratio between a 
location and the over ail mean for that day. 
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Figure 3: The ratio between the 8 locations and the Grand Mean (1) over 4 days of 
testing 
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Table legend 
Table 1: Mean PPT values of 8 locations over 4 days of testing: This table outlines the 
mean PPT values obtained at each location over the 4 days of testing. Underneath the 
table is the significant difference between locations on each day of testing. 
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Table 1 Mean PPT values of 8 locations over 4 days of testing 
Oay 1 Oay2 Oay3 Oay4 
Location (x ± 50) (x ± 50) (x::t: 50) (x ± 50) 
Location 1 150.09 ± 77.15 * 123.37 ± 79.44* 123.61 ± 81.50 * 136.83 ± 81.60 * 
Location 2 160.28 ± 72.39 * 138.00 ± 73.91 f 131.24 ± 76.81 *f 145.00 ± 77.29 * 
Location 3 174.95 ± 73.40 * 146.46 ± 77.94 f 139.37 ± 80.42f 146.33 ± 81.40 * 
Location 4 246.53 ± 78.01 f 219.77 ± 75.97 ~ 208.27 ± 76.30 ~ 220.57 ± 78.51 f 
Location 5 232.19 ± 77.77 191.21 ±74.11 187.18 ± 73.55 r 201.67 ± 76.06 ~ 
Location 6 228.79 ± 80.90f 195.18 ± 75.18 180.78 ± 82.75 r € 190.57 ± 80.92 € 
Location 7 244.70 ± 78.34 213.56 ± 76.01 207.16 ± 79.93 ~ 210.36 ± 78.34 ~ 
Location 8 211.18 ± 76.48 * 180.70 ± 72.34 € 171.57 ± 78.85 € 181.93 ± 72.16 € 
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Day 1
 
*Significantly Different from the 7 other locations (P=O.OOO - P< 0.034)
 
ISignificam Difference (P=0.045)
 
Day 2 
* Significant difference across ail 8 locations (P=O.OOO - P= 0.023)
 
1Significant difference berween ail other locations (P=O.OOO- P= 0.027) no difference between location 2 and 3 (P= 0.112)
 
~ Significant difference berween ail other locations (P=O.OOO- P= 0.003) no difference beN'een location 7 (P=.259)
 
(Significant difference beN'een ail other locations (P=O.OOO- P= 0.034) except locations 5(p=0.150) and location 6 (P=0.076)
 
Day 3 
* Significant difference between ail other locations (P=O.OOO - P=0.031), no difference berween location 1 and 2 (P=.229) 
1Significant difference between ail other locations (P=O.OOO- P=0.027) no difference between location 2 and 3 (P= 0.118) 
~ Significant difference berween ail other locations (P=O.OOO- P=0.0ü3) no difference between location 4 and 7 (P=.754) 
le Significant difference berween ail other locations (P=O.OOO- P=0.022) no difference berween 10caLion 5 and 6 (P=.342) 
€ Significant difference beN'een ail other 10caLions (P=O.OOO- P= 0.034) except between location 8 and 6 (P=0.109) 
Day 4 
• Significant difference berween ail other locations (P=O.OOO) nodifference between 10caLion 1 and 2 (P= 0.123) 
or 10caLion 1 and 3(p=0.156) or 10caLion 2 and 3 (P= 0.766) 
Significant difference berween ail other locations (P=0.000- P=0.018) 
'if Significant difference berween ail other locations (P=O.OOO- P=0.022) no difference berween location 5 and 7 (P=0.175) 
€ Significant difference berween ail other locations (P=0.000) except between 10caLion 8 and 6 (P=0.141) 
146 
CHAPTERV 
RESULTS FROM ADDITIONAL QUESTIONS 
5.01 Additional question 1: Relationship between skin fold values and PPT values 
An analysis of variance was perfonned on the skin values collected at the 8 locations. The 
main effect showed that there was a significant difference in skin fold value between the 8 
different sites (F= 10.29, p<O.05, critical F= 2.11), Table 1 Post hoc analysis showed a 
significant difference (0<0.05) between locations Tl and T2 on the one hand and ail other 
testing locations except for T8 where T1-T8 (0.26) and T2-T8 (0.07). 
Table 1: Skin-fold values of the 8 different locations 
Location Location Location Location Location Location Location Location Mean of 
l 2 3 4 5 6 7 8 aH sites 
j1=9.73 j1=8.94 j1=17.38 j1=12.36 j1=15.20 j1=13.76 j1=14.61 j1=11.15 j1=12.89 
±4.74 ±4.24 ± 6.05 ±3.40 ±7.39 ±4.05 ±3.84 ± 4.41 ±3.79 
1,2,3,4 1,2 1,2,3 1,2,3 1,2,3,4 1,2 
ANOVA: F=1 0.29, critical F=2.11, P< 0.05 
Post Hoc analysis 
1 Significant difference from location l(P< 0.05) 
2 Significant difference from location 2(P< 0.05), note Post Hoc analysis between location 2 and location 
8(p=O.07) 
3 Significant difference from location 8(P< 0.05) 
4 Significant difference from location 4(P< 0.05), note Post Hoc analysis between location 4 and location 
5(p=0.08) 
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Location 2 on the anterior de1toid was found to have the lowest skin fold values with a 
mean of 8.94 and a SD± 3.60. Location 1 on the biceps was found to have the second 
lowest skin fold values with a mean of 9.73 and a SD± 4.02. Location 3 on the triceps was 
found to have the highest skin fold values with a mean of 17.38 and a SD± 5.14. The 
mean for ail 8 locations was 12.89. 
An Analysis was performed on the relationship between ail PPT values and ail skin fold 
values. No statistical correlation was found between skin fold thickness and PPT values 
obtained at the same location as seen in figure 16. Locations 1 on the biceps and location 
2 on the anterior deltoid recorded the lowest skin fold values along with sorne of the 
lowest PPT values. Location 3 on the triceps had the highest skin fold values but had 
sorne of the lowest PPT values. When location 3 is removed frorn the group analysis, 
again no correlation was found between the skin thickness of a location and the PPT of 
the sarne location. 
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Figure16. PPT values correlated to skin fold values 
Linear Regression with 95.00%Mean Prediction Interval 
Pressure pain threshold ofday 1 = 3.79(skin-fold) +157.27 * R-Square = 0.05 
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5.02 Additional question number 2: Consistency in determining nodule status 
Table 2 shows the interclass correlation analysis that was perforrned on the agreement 
between the 2 athletic therapists on deterrnining whether a nodule was present at the 
testing location for ail 8 eight locations on ail 19 subjects. The interclass correlation was 
0.54, which is considered low but consistent with other studies of similar design (Shultz et 
al.,2006). 
A comparison between the two athletic therapists was perforrned on the pre 
algometer- testing data and on the post algometer testing data. An Intraclass correlation 
was also done comparing what each athletic therapist's found pre algometer- testing and 
compared to what was found after completion of the algometer testing stage. We do 
recognize the possibility that the nodule status may change over the testing period. 
Table 2 also lists the pre-test to post test ICC scores for each athletic therapist. The ICC 
scores for athletic therapist number 1, was 0.47 for her agreement between the pre-test 
nodule status and the post test nodule status. The ICC scores for athletic therapist number 
2, was 0.36 for her agreement between the pre-test nodule status and the post test nodule 
status. 
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Table 2 
The interc1ass correlation scores of the two athletic therapists, evaluating the 
nodule status at the 8 different locations. 
Evaluation ICC value CriticaI F ActuaI F 
Both athIetic Therapists pretest - post 0.537 2.156 1.634 
test score 
AthIetic Therapist 1 0.465 1.868 1.530 
Pretest- post test score 
Athletic Therapist 2 0.357 1.552 0.095 
Pretest- post test score 
ICC (p=O.05) 95% Confidence Interval 
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Figures 17 and 18 give a percent breakdown of the pre test and post test agreement 
between the two athletic therapists as to the nodule status. In figure 17, titled "Pre test 
agreement on nodule status at each location", location 2 anterior deltoid and location 8 
the infraspinatus were found to have the highest levels of agreement (94.74 and 84.21 %), 
location 5, the posterior deltoid, was found to have the lowest amount of agreement at 
36.84. Location 5, the posterior deltoid, was also found to have the second highest skin 
fold value. This may have been a factor in the amount of disagreement found at this 
location. The other 5 locations varied from 57.89% to 68.42%. To verify this statement a 
correlation analysis will be performed between skin fold thickness and the interclass 
correlation between the athletic therapists in a follow up paper. 
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Figure 17. Pre test agreement on nodule atatus at each location 
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Figure18 shows the "Post agreement on nodule status at each location. There was sorne 
change between pre-test and post-test agreement. There was an increase in agreement 
across 6 of the 8 locations with the exceptions of locations 2, anterior deltoid, and 8, the 
infraspinatus, which showed a decrease in agreement levels. Location 2, anterior deltoid 
is still the location with the highest agreement between the 2 athletic therapists. The 
greatest change was observed at location 5, the posterior deltoid, where agreement 
changed from 36.84% to 64.71 %. There was a small change at location 1 biceps brachii 
pre test to post test, 63.16% to 64.71 %. 
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Figure 18. Post test agreements on nodule status at each location 
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Figure 18 shows the Pre-test to Post-test comparison of nodule status for athletic therapist 
number 1. Nodule status was defined as being either the presence or absence of a trigger 
point nodule at the testing location. Locations 1, bicep brachii and 2, anterior deltoid, had 
the highest levels of agreement at 82.35 and 94.12 respectively. Location 4, rhomboids 
major, had the lowest level of agreement at 50.00% Locations 3tricep brachii, 5 posterior 
deltoid, 6 supraspinatus, 7 trapezius and 8 the infraspinatus had agreement percent 
varying between 68.75 and 76.47% 
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Figure 19. Pre-test to post-test comparison of nodule status for Athletic Therapist number 1 
Figure 19 illustrates the pre-test to post-test comparison of nodule status for Athletic 
Therapist 1. Locations 1 biceps brachii and 2 anterior deltoid had the highest levels of 
agreement 82.35-94.12%, while location 4(rhomboids major) had the lowest level of 
agreement 50.00% Locations 3 triceps brachii, 5 posterior deltoid,6 supraspinatus, 7 
trapezius and 8 the infraspinatus had agreement percent varying between 70.58 and 
76.47%. 
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Figure 20 shows the pre-test to post-test comparison of nodule status for athletic therapist 
2. Locations 1 biceps brachii and 2 anterior deltoid had the highest levels of agreement 
94.12-100.00%, while location 3(posterior deltoid) had the lowest level of 
agreement52.94% Locations 4 rhomboid major, 5 posterior deltoid,6 supraspinatus, 7 
trapezius and 8 the infraspinatus had agreement percent varying between 58.82 and 
62.50% 
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Figure 20. Pre-test to post-test comparison of nodule status for Athletic Therapist number # 2 
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5.03 Additional question number 3: Presence of a nodule and the pressure pain 
threshold values 
Figures 21 and 22 give sorne qualitative information regarding the athletic therapists 
agreement on the presence or absence of a nodule at the 8 locations. In figure 21 
locations 2, anterior deltoid, and 8, the infraspinatus, had the most agreement and location 
5 the posterior deltoid had the most disagreement in regards to nodules at the locations. 
Locations 1 biceps brachii (12), 2 anterior deltoid (17), 6 supraspinatus (12) and 8 the 
infraspinatus (15) were suspected of having the greatest number of nodules. Location 3, 
triceps brachii (7) was found to have the fewest number of nodules presence. 
In figure 22, looking at the post evaluation locations 1 biceps brachi (11), 2 anterior 
deltoid (15), 3, triceps brachii (10),6, supraspinatus (10) and 8 the infraspinatus (10) were 
suspected of having the greatest number of nodules. Location 5 posterior deltoid (8) was 
found to have the fewest number of nodules presence. 
The one location that both examiners agreed had a high probability of having a trigger 
point nodule also had one of the lowest PPT values, which was location number 2 on the 
--
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anterior deltoid.The location that was the least likely have a trigger point nodule was 
location 5- posterior deltoid and was also shown to have the second highest PPT values. 
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Figure 21. Pre-test evaluations of the 8 locations for nodule status 
Series1 Disagreement between 2 athletic therapists on whether a nodule is present on or 
not present at the location 
Series 2 Agreement between 2 athletic therapists that a nodule is present at the location 
Series 3 Agreement between 2 athletic therapists that no nodule is present at the location 
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Figure 22. Post test evaluation of the 8 locations for nodule status 
Series! Disagreement between 2 athletic therapists on whether a nodule is present on or 
Dot present at the location 
Series 2 Agreement between 2 athletic therapists that a nodule is present at the location 
Series 3 Agreement between 2 athletic therapists that no nodule is present at the location 
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5.04 Additional question number 4: Variation in PPT values 
Figures 22 through 24 show considerable variation between subjects in PPT values 
obtained at the lateral head of the triceps muscle (figure 23), trapezius (figure 24) and the 
infraspinatus (figure 25). The variation between subjects was present for aH 8 locations 
over the 4 consecutive days of testing. 
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Figure 23. PPT values obtained at location 3, the triceps 
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Figure 24. PPT values obtained at location 7, the trapezius 
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CHAPTERVI 
DISCUSSION ON ADDITIONAL QUESTIONS 
6.01 Additional question 1: Relationship between skin fold values and PPT 
values 
It was expected that wornen with higher skin fold values (greater amounts of adipose 
tissue) would have higher PPT values and that wornen with lower skin fold values (iower 
arnounts of adipose tissue) would have lower PPT values. This tumed out to be not true. 
There appeared to be no correlation (Figure 16) between skin fold thicknesses at a 
location and how high or low were the associated PPT values. 
An Analysis was performed on the relationship between aIl PPT values and aIl skin fold 
values. There was no statistical correlation between skin fold thickness and pressure pain 
threshold as seen in Figurel6. When individual locations were evaluated, sorne of the 
locations came close to having a correlation. A good exarnple of this was shown at 
locations 1, biceps brachii, and 2, anterior deltoid; both locations had sorne of the lowest 
recorded skin fold values along with sorne of the lowest PPT values. However, location 3 
on the triceps had the highest skin fold values but had sorne of the lowest PPT values. 
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Even though this aspect of the project did not support our original hypothesis it is very 
useful information that other researchers may want to evaluate. There is an assumption 
(Glickman-Weiss et al., 1999), that the larger the amount of adipose tissue "the more 
padding" an individual has and the more likely he/she is able to tolerate greater levels of 
pain and discomfort. This theory appears to hold true when looking at how higher skin 
fold values help insulate an individual to tolerate colder climates (Glickman-Weiss et al., 
1999; Prisby et al., 1999). This insulation effect does not appear to be factor when 
tolerating mechanical pressure; if it did, we would have seen higher PPT values closely 
correlated to higher skin fold measures. This did not take place. This information will be 
presented in greater detail in a research paper outlining the methodology and results on 
the relationship between PPT and skin fold. 
One subject who did have a higher than average body mass index also had high PPT 
values. In fact, aIl PPT values were recorded at 400 kilopascals, which was our eut off 
point for the application of the algometer. It is possible that the subject's PPT values may 
have been much higher than what was registered. This individual appeared to have little 
variation in PPT values at the 8 locations and appeared to have a very high PPT. This 
subject had been previously in the Canadian military for several years, which may have 
been a contributing factor to her high PPT values. 
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6.02 Additional question 2: Consistency in determining nodule status 
It was expected that there would be a high level of consistency between the two athletic 
therapists at detennining whether a nodule was present or absent at each of the 8 different 
locations. Table 2: shows that the intertester correlation score between the two athletic 
therapists was 0.54, which is considered low (Shultz et al., 2006). The score is lower than 
(0.45-0.80) observed in other studies (Al-Shenqiti and Oldham, 2005; Shultz et al., 2006; 
Tunks et al., 1995) that have looked at the correlation between different clinicians' ability 
to locate stmctures using manual techniques, such as palpation. One significant difference 
between our study and many other studies (Al-Shenqiti and Oldham, 2005; Shultz et al., 
2006; Tunks et al., 1995) is the subjects who are being evaluated. The subjects in our 
project were not experiencing any musculoskeletal problems at the time of testing. 
Subjects in other projects were patients being evaluated for musculoskeletal problems. 
Other studies did only try and feel for a nodule in the tissue (Al-Shenqiti and Oldham, 
2005; Shultz et al., 2006) these studies also looked for a withdrawal response on the part 
of the subject, because of pain at the testing location. 
A second thing that should be considered with the data from Table 2 is the restraints that 
were placed on the two athletic therapists. The subjects were not allowed to give either of 
the athletic therapists any verbal feedback while the palpation process was being 
performed. This is a more stringent protocol than in other studies (Al-Shenqiti and 
Oldham, 2005), where limited feedback by the subject was information therapists used to 
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determine nodule status. In this study no verbal feedback was given to the therapists by 
the subjects. This was done to avoid biasing the athletic therapists who were performing 
the evaluation. 
In figure 17, titled "The pre test agreement on nodule status at each location", location 2, 
anterior deltoid, and location 8, the infraspinatus, were found to have the highest levels of 
agreement (94.74 and 84.21 %), location 5 the posterior deltoid was found to have the 
lowest amount of agreement at 36.84%. Location 5 the posterior deltoid was also found to 
have the second highest skin fold value. The thickness in the location may have been a 
factor in the amount of disagreement found at this location. The other 5 locations varied 
from 57.89% to 68.42%. 
In Figure18 titled ''The post test agreement on nodule status at each location" we see the 
post agreement on nodule status at the 8 locations. There was sorne change between pre­
test and post-test agreement. There was an increase in agreement across 6 of the 8 
locations with the exceptions of locations 2, anterior deltoid, and 8, the infraspinatus, 
which showed a decrease in agreement levels. Location 2, anterior deltoid, was still the 
location with the highest agreement between the 2 athletic therapists. The greatest change 
took place at location 5, the posterior deltoid, where agreement changed from 36.84% to 
64.71 %. There was a small change at location 1, biceps brachi, pre test to post test, 
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63.16% to 64.71 %. The overall improvement in agreement percentage maybe related to 
the athletic therapists starting to become more familiar with the locations being palpated 
on each subject. 
Figures 19 and 20 looked at the pre-test to post-test agreement on nodule status for 
athletic therapist 1 and athletic therapist 2. It looked at whether the athletic therapist 
changed their opinion on whether a nodule was present at the location or whether it was 
absent. Subjectively looking at the 2 figures, it appears that athletic therapist 1 showed 
more consistency in deterrnining nodule status compared to athletic therapist 2. This is 
because athletic therapist 1 did not have as much variation pre test to post test compared 
to athletic therapist 2. 
The possible change in nodule status may have been related to the testing protocol of the 
project. The algorneter was applied to each of the locations over 4 consecutive days. The 
repeated application of the algometer may have facilitated a change in the tissue of sorne 
of the subjects. Change may have been a reduction in a nodule that was present or the 
development of a nodule at the testing location where no nodule was previously present. 
This potential change would have influenced the results on the part of the Athletic 
Therapist. 
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Clinicians, who treat vanous fonns of musculoskeletal disorders, place a significant 
emphasis on their ability to identify problem areas in soft tissue, such as being able to 
locate a nodule like structure associated with a trigger point. It is believed that the 
presence of a trigger point nodule may be contributing to the underlying problem of the 
patient. It is clear from the data collected from the two athletic therapists that actually 
knowing whether a nodule is present in the tissue is a challenge. Having verbal feedback 
from the patient, along with noting a withdrawal response would have made a significant 
difference in the interclass correlation scores (Scoitti et al., 2001). 
The infonnation collected on Interclass correlation and Intraclass correlation will 
comprise a separate paper, which will be of interest to clinicians. 
6.03 Additional question 3: Presence of a nodule and PPT values 
The third additional question that was asked concemed the relationship between the 
presence of a trigger point nodule and PPT values that would be obtained. It was 
hypothesised that locations where a trigger point nodule was found to be present that a 
lower PPT value would be obtained. This would be in comparison to a location where no 
trigger point nodule was located and a higher PPT value would be obtained. 
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Figures 21 and 22, gives sorne qualitative infonnation regarding the athletic therapist's 
agreement on the presence or absence of a nodule at the 8 locations. In figure 21, 
locations 2, anterior deltoid, and location 8, infraspinatus, had the most agreement 
between the 2 athletic therapists while location 5, the posterior deltoid had the least 
amount of agreement in regards to the presence or absence of a trigger point nodule at the 
testing locations. Locations 1, biceps brachii (12), 2 anterior deltoid (17), 6 supraspinatus 
(12) and 8 infraspinatus (15) were suspected of having the greatest number of nodules. 
Location 3 triceps brachii (7) was found to have the fewest number of nodules presence. 
In figure 22, looking at the post evaluation locations 1 biceps brachii (11), 2, anterior 
deltoid (15), 3, triceps brachii (10), 6, supraspinatus (10) and 8, infraspinatus (10), were 
suspected of having the greatest number of nodules. Location 5 posterior deltoid (8) was 
found to have the fewest number of nodules presence. 
The one location that both examiners agreed had a high probability of having a trigger 
point nodule also had one of the lowest PPT values and this was location number 2 on the 
anterior deltoid. The location that was the least likely to have a trigger point nodule was 
location 5, posterior deltoid, and was also shown to have the second highest PPT values. 
The infonnation regarding nodule status and PPT will comprise a final paper. 
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6.04 Additional question 4: Variation in pressure pain threshold values 
We hypothesised that the same location on different individuals would have different PPT 
values. This is consistent with the idea that PPT may be highly variable depending on the 
individual. This individual variation certainly adds to the challenge of evaluating pain. 
This infonnation has been shown in other studies and gives the reader a better 
understanding of how subjective pain is to different people. 
Figures 23 through to 25 give a graphie representation of the PPT of ail 19 subjects at 3 of 
the 8 different locations over 4 consecutive days of testing. At least two observations may 
be readily noted from the 3 charts. The first observation is that subject number 1 had 
consistently high PPT values that were over 400 kilopascals for almost aU of the recorded 
sessions. The subject rarely pressed the hand-held switch (red button in Figure 2) of the 
algometer to indicate her PPT had been reached. During the testing period, the data 
collector was frequently required to stop applying the algometer to the testing location 
because the 400 kilopascal mark had been reached on this subject. The 400 kilopascal 
mark was the predetennined point when the algometer was to be removed from the 
location to avoid tissue damage. It was important that this safeguard was in place and 
adhered by the data collector so as to protect the subjects from potential injury. It is 
actually unknown what the true PPT is for subject number 1. 
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There are some rare individuals who do not feel any pain. These subjects may go through 
their lives without experiencing any significant pain, which most of us experience to 
varying extents on a daily basis (Minde et al., 2004). These people have been found to be 
normal psychologically and physiologically but a genetic anomaly prevents them from 
feeling pain. These people have been known to walk around with major displaced 
fractures (tibia-fibula, etc.) and will feel more inconvenienced than uncomfortable (Minde 
et al 2006). Unfortunately these individuals end up dying at a rather young age (teenager 
to early twenties) often due to a major incident where a large volume of blood is lost and 
total system failure occurs (Danziger, Prkachin and Willer,2006; Minde et al., 2006). 
The second observation conceming Figure 23 through 25 is that there was a lot of 
variation in the PPT values in 19 subjects, even though their may have been some 
similarity between individual subjects at certain locations, the values were different. 
With the second observation, we expected to find variation in PPT values in the sarne 
location between each of the subjects. This does not take away from what we have 
outlined in Chapter IV, that different locations on the body have varying degrees of 
sensitivity, where sorne locations may be more sensitive than other locations. This does 
reinforce the fact that pain is a multidimensional problem and we have been able to 
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evaluate only one component. It is hoped that this infonnation may be combined with 
other physiological, psychological, cultural and spiritual tools to address pain. 
6.05 Conclusion and potential benefits of the project 
Pain is a muIti dimensional problem that afflicts large populations from many different 
disciplines. The goal of this project was to develop a diagnostic tool that may address one 
component of the problem with pain in the arm shoulder and neck regions. The 
hypothesis that the PPT values will vary in different locations has been shown to be valid. 
The unexpected finding in this project was the drop in an individual's PPT values from 
one day of testing to day two of testing. Taking both factors,l)the variation in PPT values 
between day land day 2 and 2) the regional variation between testing locations, will 
allow the protocol to be used in the next stage of the project. The second stage being to 
work with women who are about to undergo breast surgery, related to breast cancer and to 
identify individuals who have greater predisposition to upper extrernity problems, even 
though they are presently asymptomatic. We would expect variation at the 8 different 
testing locations. Locations on the upper ann and anterior shoulder will have lower PPT 
values, the posterior shoulder and posterior torso should have somewhat higher PPT 
values. 
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6.06 Precautions 
In the medical field, diagnostic tools are used to identify pathologies so that appropriate 
treatment regimes maybe administered to people suffering from various disorders. Before 
you are able to effectively treat someone you should have an idea what it is you are 
treating. 
The same tools that the medical profession use to help individuals may a)so be used by 
businesses and in particular, insurance companies for less than honourable reasons. This 
may include denying health insurance coverage to those who have had breast cancer or 
have been identified as having the BRAC! or BRAC2 type gene. 
This is certainly a problem in many countries including Canada. 
Should we stop developing diagnostic tools to help reduce the suffering of patients? 
Definitely not, we need to continue to develop and implement ethical guidelines and the 
appropriate government regulatory bodies; to make sure that the misuse and abuse of 
diagnostic tools of does not occur. 
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Annex 1 
Consentement de participation à un projet de recherche 
Je, , accepte de participer à un programme de 
recherche conjoint mené par l'Université du Québec à Montréal et l'université Concordia. 
Le projet de recherche est sous la supervision de Alain Comtois Ph.D., professeur régulier 
au département de Kinanthropologie à l'Univers.ité du Québec à Montréal et de Robert D. 
Kilgour, Ph.D., FACSM, professeur aggrégé au département de Exercise Science à 
l'université Concordia. L'équipe de recherche est composée de monsieur David Jones, 
étudiant à la maîtirse à l'Université du Québec à Montréal et Tracy Griffiths et Christina 
Grace qui sont deux thérapeutes du sport au département de Exercise Science à 
l'université Concordia. 
A. Objectif 
J'ai été informé que le but du projet de recherche est de détenniner la validité d'un 
appareil de mesure connu sous le nom d'algomètre mesurant les seuils de douleur à la 
pression de points gachettes situés à des endroits variés aux niveaux du cou, des épaules 
et des bras. 
B. Procédures 
Tous les tests utilisant l'algomètre seront menés au pavillon des sciences Richard J. 
Renaud situé au campus Loyala de l'université Concordia. Les procédures expérimentales 
se dérouleront comme suit: 
Je devrai être disponible pour les évaluations durant une période de quatre jours 
consécutifs. La première journée prendra une heure de votre temps et ensuite 45 min par 
jour pour les autres journées. Donc, un total de près de 3V2 heures sera requis de votre 
part. 
1. Le premier jour des évaluations devra coïncider avec le dernier jour de mon cycle 
menstruel normal. 
2. Lors de la première rencontre pour le projet, mon épaule droite sera examinée à 
l'aide de palpation par deux thérapeutes sportifs (Tracy Griffiths et Christina Grace) 
participant au projet Chacune des thérapeutes effectuera une évaluation indépendante de 
mon épaule visant à identifier la présence d'un nodule possible aux sites potentiels des 
points gachettes. Par la suite, les thérapeutes se consulteront et marqueront 8 petits points 
(à l'aide d'un crayon feutre indélébile) sur et autour de mon épaule droite. Je ne devrai 
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pas enlever ces points d'encre durant les 4 jours d'évaluations. Des mesures concernant 
ma grandeur et mon poids seront aussi prises à cette première rencontre. 
3. Au cours de cette même journée je vais rencontrer la personne en charge de la 
prise de données (Dave Jones). Je ne devrai pas discuter des données enregistrées avec 
cette personne ainsi qu'avec toutes les personnes impliquées dans cette étude. 
4. La personne en charge de la prise de données appliquera un algomètre manuel sur 
les huit points marqués aux niveaux de mon cou, mon épaule et de mon bras du côté droit. 
L'algomètre mesurera les seuils de douleur à la pression sur les huit points marqués à 
l'encre. Je devrai aviser (à l'aide d'un interrupteur situé dans ma main) la personne en 
charge de la prise de données lorsque la pression appliquée changera de la sensation de 
pression à celle de douleur. Trois (3) séries de données seront enregistrées. 
5. Je devrai prendre rendez-vous avec la personne en charge de la prise de données 
pour les trois journées subséquentes d'évaluation. 
6. La première évaluation devrait durer environ 2 heures. Les évaluations suivantes 
dureront en moyenne 45 minutes. Chaque évaluation sera planifiée à l'avance et je devrai 
aviser les chercheurs à l'avance si je ne suis pas en mesure de participer à une de ces 
séances. 
C. Risques reliés à la participation 
Je pourrais ressentir de la douleur à un ou plusieurs des points marqués à la suite de 
l'application de l'algomètre. Au cours des tests physiques, je devrai effectuer la tâche 
jusqu'au moment où je jugerai que le niveau d'inconfort n'est plus tolérable. 
D. Les bénéfices reliés à la participation 
Les bénéfices de participer à ce projet de recherche se situent dans deux catégories: une 
personnelle et une collective. 
a. À un niveau personnel, il existe peut-être un ou deux endroits autour de mon cou, 
épaule ou bras qui peuvent être identifiés comme étant hypersensible. Sachant que ces 
endroits sont sensibles et pourraient éventuellement devenir problématique m'aidera à 
mettre en place une stratégie préventive afin de réduire le potentiel de risque éventuelle au 
niveau de mon cou, épaule et bras. 
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b. À un niveau collectif, la douleur au cou, épaule et bras touche énonnément de 
personnes issues de milieux différents. Les informations recueillies nous aiderons à 
valider l'efficacité de l'algomètre à évaluer la douleur dans la région du cou, des épaules 
et des bras. L'algomètre pouna ainsi être utilisé pour évaluer l'efficacité de différents 
types de traitement pour diminuer la douleur, tel que, par exemple, la réorganisation de 
poste de travail ou l'utilisation de la glace au niveau de l'épaule. 
Il est clairement attendu que je participe à cette étude de façon purement volontaire et que 
je suis complètement libre de me retirer à n'importe quel moment de l'étude en cours sans 
me causer de préjudice défavorable. 
Tous les renseignements recueillis durant cette étude sont strictement confidentiels et ne 
seront pas transmis d'aucunes façons à qui que ce soit sans mon autorisation écrite remise 
aux chercheurs responsable de l'étude. Par contre, ces infonnations pourront être utilisées 
afin d'avancer le niveau des connaissances scientifiques et pourront être publiées dans des 
revues scientifiques en s'assurant que mon anonymat soit maintenu. 
E. Sujets 
En tant que sujet, je suis une femme âgée entre 20 et 45 ans. Je n'ai connu aucunes 
complications au niveau de l'épaule durant les six derniers mois et à ma connaissance 
actuelle je n'ai pas d'autres problèmes médicaux qui m'empêcheraient de participer à 
cette étude. Je reconnais que le cycle menstruel affecte le seuil de détection de la pression 
à la douleur que nous allons mesurer et actuellement j'ai un cycle menstruel régulier qui 
dure entre 26 à 31 jours. Il est attendu que je ne prends pas de contraceptifs oraux. TI est 
aussi attendu que je ne consommerai pas de breuvage caféiné au moins une heure avant le 
début de l'expérimentation et il est aussi attendu que je vais m'abstenir de consommer un 
analgésique (ex., aspirin) au moins 8 heures avant le début de l'expérimentation. 
F. Questions 
Vous êtes totalement libre de poser des questions que vous jugez pertinentes. Toutes 
questions sur le projet de recherche, plaintes ou commentaires peuvent être adressés à 
tous les membres du personnel impliqué dans ce projet de recherche. De plus, vous êtes 
invité à demander des explications additionnelles si vous avez le moindre doute. Les 
responsables de la recherche sont Alain Comtois, directeur du projet de maîtrise, Robert 
D. Kilgour, co-directeur du projet de maîtrise et Dave Jones, étudiant à la maîtrise. Les 
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coordonnées respectives de ces trois personnes sont fournies à la fin de ce formulaire de 
consentement. 
De plus, ce projet de recherche a reçu l'approbation du Comité d'éthique du Département 
de kinanthropologie et les coordonnées apparaissent au bas du présent formulaire de 
consentement. 
Pour toutes questions touchant la responsabilité des chercheurs ou dans l'éventualité où la 
plainte ne peut leur être adressée directement, vous pouvez faire valoir votre situation 
auprès du sous-comité du Comité institutionnel d'éthique de la recherche chez l'humain 
(CIÉR) de l'UQÀM aux coordonnées apparaissant au bas du présent formulaire de 
consentement. 
Je suis satisfait des explications reçues et j'ai lu attentivement la démarche de l'étude. J'ai 
pris connaissance des risques possibles de participer à cette recherche tel que décrite dans 
le présent formulaire de consentement et j'accepte de participer en tant que sujet dans ce 
projet de recherche intitulé: L'utilisation de l'algomètre sur les points gachettes de la 
région du cou, de l'épaule et du bras. 
____ ,2005Date:
----- ­
(mois) Uour) 
Nom: Signature: _ 
(Lettres moulées) 
Témoin: Signature: ---'­
(Lettres moulées) 
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Coordonnées: 
Alain-S. Comtois, Ph.D. :numéro de téléphone: (514) 987-3000 poste 1506 
adresse électronique: comtois.alain-steve@ugam.ca 
Robert D. Kilgour, Ph.D.:numéro de téléphone: (514) 848 2424 extension 3322 
adresse électronique: kilgour@alcor.concordia.ca 
Dave Jones, B.Sc., CAT :numéro de téléphone: (514) 848 2424 poste 3318 
adresse électronique: dhjones@vax2.concordia.ca 
CIÉR de l'UQÀM :secrétariat du Comité: service de la recherche et de la création 
Université du Québec à Montréal 
c.P. 8888, succursale Centre-ville 
Montréal, QC 
H3C 3P8 
Numéro de téléphone: (514) 987-3000 poste 7753 
Adresse électronique: src@ugam.ca 
Département de kinanthropologie :Université du Québec à Montréal 
Case postale 8888, succursale Centre-ville 
Montréal (Québec) Canada 
H3C 3P8 
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Annex2 
Consent Form to Participate in Research 
1, , agree to participate in a joint program of 
research being conducted by the Université du Québec à Montréal and Concordia 
University. This research project will be supervised by Alain Comtois Ph.D., professeur 
régulier, in the Department of Kinanthropologie at Université du Québec à Montréal and 
by Robert D. Kilgour, Ph.D., FACSM, who is an Associate Professor in the Department 
of Exercise Science at Concordia University. The research team includes David Jones,.a 
Graduate student at the Université du Québec à Montréal, Tracy Griffiths and Christina 
Grace both of whom are athletic therapists in the Department of Exercise Science at 
Concordia University. Completing the research is Ron Rehel M.Sc., from the Department 
of Exercise Science at Concordia University, who will act as the second data collector. 
A. Purpose 
l have been infonned that the purpose of the research is to deterrnine the validity of using 
a measuring devise know as an Algometer to assess pressure pain thresholds of different 
trigger point locations in the neck, the shoulder an ann regions. 
B. Procedures 
Ail tests using the Algometer will be conducted at the Richard 1. Renaud, Science 
Pavilion on the Loyola Campus of Concordia University. The following summarizes the 
protocol of experimental procedures: 
7.	 l will be asked to make myself available on four consecutive days of testing. 
8.	 The very first day of testing will coincide within the last four days of my normal 
menstrual cycle. 
9.	 At my first meeting for the project, my right shoulder will be palpated by two 
experienced athletic therapist (Tracy Griffiths and Christina Grace) who are 
members of the project. Each athletic therapist will be evaluating my shoulder on 
their own, looking for any nodule structures at potential trigger point locations. 
The two athletic therapists will then confer with each other and place a small ink 
mark on eight different locations in and around my right shoulder. l will be asked 
not to remove the ink mark over the 4 days of testing. Measurements of my height 
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and weight will also be recorded on this day.(The palpation of the trigger point 
locations, by the two athletic therapists, will be repeated within one day, after the 
completion of the last set of algometer measures. 
10. On the same day l will then meet with the Data collector (Dave Jones). l will be 
asked not to discuss any of the recorded information with the Data collector. l will 
also be asked to not discuss my recorded information with any one else connected 
to the study. 
Il. The Data Collector will apply a hand held Algometer to eight different landmarks 
in and around neck shoulder and arm on the right side of my body. The Algometer 
will measure pressure pain thresholds at eight different landmarks. l will 
irnrnediately indicate to the data collector (via a hand held switch) when the 
pressure from the Algometer changes from the sensation of only pressure to 
pressure/pain or pain. Three complete sets of data will be collected. 
12. l will make arrangements to meet with the Data collector for the subsequent three 
days. 
13. The first testing session is expected to last approximately 2 hours in total. 
Subsequent testing will require approximately 45 minutes of my time to complete. 
Each session will be scheduled in advance and l will advise the researchers in 
advance if l am unable to participate on the scheduled day. 
14. Within 5 days of completion of testing, l will have a series of skin fold measures 
taken at the same trigger point locations. This will involve a skin fold calliper 
being applied to my skin surface. Two data collectors will be involved in this 
process. One data collector will fold the skin surface, while the second data 
collector will apply the skin fold calliper to obtain the measures. 
c. Risks of participation 
l may experience pain at one or more of the Iandmarks following the application 
of the algometer. As weIl, during the physical tests l will be asked to conduct the 
task until the Ievel of discomfort is no longer tolerable. 
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D. Benefits of participation 
The benefits of my participation in this project fall into two categories. The first 
on a personnellevel and the second on a collective level: 
a.	 On a personnellevel, there may be one or more landmarks in and around 
my neck, shoulders and arms which may be identified as being 
hypersensitive. Knowing that the landmarks are sensitive may become 
problematic in the future can help me to implement sorne preventative 
strategies to decrease my risk of developing neck, shoulders problem. 
b.	 On a collective level, pain in around the neck, shoulder and arm afflict 
large groups of women from various backgrounds. This being the first 
phase of a three phase project, the information collected will help to 
validate the effectiveness of an Algometer in assessing pain in the neck 
shoulder and arm region. The Algometer may then be used to evaluate the 
effectiveness of various treatment regimes at diminishing pain, such as 
cooling of injured areas. 
1 am participating in this experiment on a strictly volunteer basis and 1 am free to 
withdraw at any time prior to or during the experimental session. 
All the information obtained during the course of this study is strictly confidential 
and will not be released to anyone without my written consent to the researchers. 
However, this information may be used to advance the body of scientific 
knowledge and may therefore be published in scientific journals where my 
anonymity will be entirely preserved. 
E. Subjects 
As a subject, 1 am female, between the ages of 20 and 45 years of age. 1 have had no 
shoulder problems over the last six months and 1 have no other known medical problem 
which may exclude me from participating in this project. 1 understand that a woman's 
menstrual cycles affect the pressure pain threshold values that will be obtained. 1 have 
regular menstrual cycles that last between 26 and 31days. 1 will be asked whether or not 1 
am using oral contraceptive medication, to determine if the medication has an impact on 
the pressure pain threshold values than are being obtained. 
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As a subject in the project, l will be asked to refrain from consuming any caffeine 
products for at least four hours before participating in the testing protocol. l will also be 
asked to refrain from ingesting an analgesic medication (ex., aspirin) for at least 24 hours 
prior to my participation in the testing protocol. l will refrain from applying any oils, 
creams or lotions to the areas marked as trigger point locations. l will be asked not to 
undertake any new physical activity, especially if that activity involves the upper body, 
which may have an impact on pressure pain threshold values 
F. Questions 
You are entirely free to ask any question that you believe is relevant. Any question about 
the project, complaints, or comments may be addressed to any of the investigators 
involved in this research project. In addition, you are invited to ask any type of additional 
explanations if you have any doubts about your willingness to participate in this research 
project. The investigators responsible for this research project are Alain Comtois, thesis 
director, Robert D. Kilgour, thesis co-director and Dave Jones, master's student. The 
coordinates where these individuals may be reached are listed at the end of this consent 
fonn. 
In addition, this research project as received approval by the institutional local ethics 
cornmittee of the department of kinanthropologie at UQAM. The ethics committee 
coordinates may also be found at the end of this consent fonn. 
For any other questions that you may have regarding the responsibility of the 
investigators or in the eventualjty that any complaint may not be addressed directly to 
them, you may contact directly the UQAM institutional ethics cornmittee {in French: 
sous-comité du Comité Institutionnel d'Éthique de la Recherce chez l'Humain (CIÉR) de 
l'UQAM} at the coordinates provided, as weil, at the end of this consent fonn. 
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1 am satisfied of the explanations that 1 have received and l have fully read the
 
procedures. 1 am aware of the risks involved in participating in these experiments outlined
 
in this consent form. 1consent to be a subject in the research project entitled "The use of
 
an algometer on trigger points in the neck, shoulder and arm region"
 
Date: _ ____ ,2006 
Name: Signature:	 _ 
(Print) 
Witness: Signature:	 _ 
(Print) 
Coordinates: 
Alain-S. Comtois, Ph.D.:	 Telephone number: (514) 987-3000 extension 1506 
E-mail: comtois.alain-steve@ugam.ca 
Robert D. Kilgour, Ph.D.:	 Telephone number: (514) 848 2424 extension 3322 
E-mail: kilgour@alcor.concordia.ca 
Dave Jones, B.Sc., CAT:	 Telephone number: (514) 848 2424 extension 3318 
E-mail: dhjones@vax2.concordia.ca 
cIÉR at UQÀM:	 secrétariat du Comité: service de la recherche et de la création 
Université du Québec à Montréal 
C.P. 8888, succursale Centre-ville 
Montréal, QC 
H3C 3P8 
Telephone number: (514) 987-3000 extension 7753 
E-mail: src@ugam.ca 
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